Cluster composition

Functions

Category	Name	IntersectionWithQuery	PValue	GenesInTerm	GenesInQuery	GenesInTermInQuery	ID
GeneOntologyMolecularFunction	olfactory receptor activity	OR7G1 OR8J3 OR11G2 OR4A47 OR5B17 OR8J1 OR11H6 OR3A1 OR12D3 OR51B6 OR7G2 OR4A4P OR5AP2	1.79e-04	431	183	13	GO:0004984
GeneOntologyMolecularFunction	G protein-coupled receptor activity	OR7G1 OR8J3 HTR2B OR11G2 OR4A47 OR5B17 OR8J1 GRM5 ADGRG4 OR11H6 OR3A1 GPR146 OR12D3 OR51B6 AGTR1 ADGRE5 OR7G2 OR4A4P OR5AP2 GP1BA	1.84e-04	884	183	20	GO:0004930
GeneOntologyMolecularFunction	transmembrane signaling receptor activity	GABRE OR7G1 OR8J3 HTR2B OR11G2 OR4A47 OR5B17 OR8J1 GRM5 ADGRG4 GFRA1 OR11H6 OR3A1 GPR146 OR12D3 PTPRM IL1RAPL2 OR51B6 AGTR1 ADGRE5 OR7G2 ALK UNC5D OR4A4P OR5AP2 GP1BA	2.68e-04	1353	183	26	GO:0004888
GeneOntologyMolecularFunction	guanyl-nucleotide exchange factor activity	MYCBP2 ARHGEF5 MCF2L2 RCC2 DOCK5 SBF1 EIF2B4 DOCK7 FGD6	2.89e-04	231	183	9	GO:0005085
GeneOntologyMolecularFunction	protein kinase A catalytic subunit binding	RYR2 PRKAR2A PRKAR2B	3.88e-04	16	183	3	GO:0034236
GeneOntologyMolecularFunction	ligand-gated monoatomic ion channel activity	GABRE TTYH3 RYR1 RYR2 KCNJ2 KCNJ12 SCNN1A KCNJ18	4.17e-04	193	183	8	GO:0015276
GeneOntologyMolecularFunction	ligand-gated channel activity	GABRE TTYH3 RYR1 RYR2 KCNJ2 KCNJ12 SCNN1A KCNJ18	4.78e-04	197	183	8	GO:0022834
GeneOntologyMolecularFunction	ryanodine-sensitive calcium-release channel activity	RYR1 RYR2	4.95e-04	4	183	2	GO:0005219
GeneOntologyMolecularFunction	extracellular matrix constituent, lubricant activity	MUC17 MUC4	4.95e-04	4	183	2	GO:0030197
GeneOntologyMolecularFunction	nucleoside-triphosphatase regulator activity	HTR2B MYCBP2 ARHGEF5 MCF2L2 RCC2 DOCK5 DLC1 SBF1 EIF2B4 ERRFI1 DOCK7 FLCN FGD6	8.33e-04	507	183	13	GO:0060589
GeneOntologyMolecularFunction	GTPase regulator activity	HTR2B MYCBP2 ARHGEF5 MCF2L2 RCC2 DOCK5 DLC1 SBF1 EIF2B4 ERRFI1 DOCK7 FLCN FGD6	8.33e-04	507	183	13	GO:0030695
GeneOntologyMolecularFunction	gated channel activity	GABRE CACNA1E TTYH3 RYR1 RYR2 CACNG2 KCNJ2 KCNJ12 SCNN1A KCNJ18	1.06e-03	334	183	10	GO:0022836
GeneOntologyMolecularFunction	monoatomic ion channel activity	GABRE CACNA1E TTYH3 PKD1L2 RYR1 RYR2 CACNG2 KCNJ2 KCNJ12 SCNN1A TRPM1 KCNJ18	1.12e-03	459	183	12	GO:0005216
GeneOntologyMolecularFunction	calcium-induced calcium release activity	RYR1 RYR2	1.22e-03	6	183	2	GO:0048763
GeneOntologyMolecularFunction	calcium channel activity	CACNA1E PKD1L2 RYR1 RYR2 CACNG2 TRPM1	1.22e-03	129	183	6	GO:0005262
GeneOntologyMolecularFunction	metal ion transmembrane transporter activity	CACNA1E PKD1L2 RYR1 RYR2 CACNG2 MFSD2A KCNJ2 KCNJ12 SCNN1A TRPM1 KCNJ18 SLC25A28	1.25e-03	465	183	12	GO:0046873
GeneOntologyMolecularFunction	monoatomic cation channel activity	CACNA1E PKD1L2 RYR1 RYR2 CACNG2 KCNJ2 KCNJ12 SCNN1A TRPM1 KCNJ18	1.29e-03	343	183	10	GO:0005261
GeneOntologyBiologicalProcess	inorganic ion transmembrane transport	GABRE CACNA1E HTR2B TCN2 ABCC5 TTYH3 ACTN2 PKD1L2 DYSF RYR1 RYR2 CACNG2 KCNJ2 KCNJ12 AGTR1 SCNN1A PLCB3 TRPM1 KCNJ18 SLC25A28 NNT WNK3 GP1BA	3.93e-05	1017	184	23	GO:0098660
GeneOntologyBiologicalProcess	inorganic cation import across plasma membrane	CACNA1E KCNJ2 KCNJ12 AGTR1 SCNN1A TRPM1 KCNJ18 WNK3	4.18e-05	142	184	8	GO:0098659
GeneOntologyBiologicalProcess	inorganic ion import across plasma membrane	CACNA1E KCNJ2 KCNJ12 AGTR1 SCNN1A TRPM1 KCNJ18 WNK3	4.18e-05	142	184	8	GO:0099587
GeneOntologyBiologicalProcess	G protein-coupled receptor signaling pathway	GPRASP1 OR7G1 OR8J3 HTR2B OR11G2 OR4A47 OR5B17 OR8J1 ACTN2 GRM5 ADGRG4 OR11H6 OR3A1 GPR146 OR12D3 GUCY2F OR51B6 AGTR1 C3 ADGRE5 PLCB3 TRPM1 OR7G2 ALK OR4A4P OR5AP2 FOXC1 GP1BA	4.56e-05	1395	184	28	GO:0007186
GeneOntologyBiologicalProcess	monoatomic ion transmembrane transport	GABRE CACNA1E HTR2B TCN2 ABCC5 TTYH3 ACTN2 PKD1L2 DYSF RYR1 RYR2 CACNG2 KCNJ2 KCNJ12 AGTR1 SCNN1A SFXN2 PLCB3 TRPM1 KCNJ18 SLC25A28 NNT WNK3 GP1BA	5.77e-05	1115	184	24	GO:0034220
GeneOntologyBiologicalProcess	inorganic cation transmembrane transport	CACNA1E HTR2B TCN2 ABCC5 ACTN2 PKD1L2 DYSF RYR1 RYR2 CACNG2 KCNJ2 KCNJ12 AGTR1 SCNN1A PLCB3 TRPM1 KCNJ18 SLC25A28 NNT WNK3 GP1BA	7.89e-05	922	184	21	GO:0098662
GeneOntologyBiologicalProcess	phospholipase C-activating angiotensin-activated signaling pathway	ACTN2 AGTR1	7.92e-05	2	184	2	GO:0086097
GeneOntologyBiologicalProcess	monoatomic cation transmembrane transport	CACNA1E HTR2B TCN2 ABCC5 ACTN2 PKD1L2 DYSF RYR1 RYR2 CACNG2 KCNJ2 KCNJ12 AGTR1 SCNN1A PLCB3 TRPM1 KCNJ18 SLC25A28 NNT WNK3 GP1BA	1.07e-04	942	184	21	GO:0098655
GeneOntologyCellularComponent	T-tubule	DYSF RYR1 KCNJ2 KCNJ12 PRKAR2A KCNJ18	7.21e-05	79	185	6	GO:0030315
GeneOntologyCellularComponent	presynaptic intermediate filament cytoskeleton	NEFM NEFL	2.32e-04	3	185	2	GO:0099182
GeneOntologyCellularComponent	sarcolemma	DYSF RYR1 RYR2 KCNJ2 KCNJ12 PRKAR2A PLCB3 KCNJ18	2.99e-04	190	185	8	GO:0042383
GeneOntologyCellularComponent	postsynaptic intermediate filament cytoskeleton	NEFM NEFL	4.62e-04	4	185	2	GO:0099160
GeneOntologyCellularComponent	calcium channel complex	CACNA1E RYR1 RYR2 CACNG2 CATSPERG	4.75e-04	73	185	5	GO:0034704
GeneOntologyCellularComponent	monoatomic ion channel complex	GABRE CACNA1E TTYH3 RYR1 RYR2 CACNG2 KCNJ2 KCNJ12 SCNN1A KCNJ18 CATSPERG	5.70e-04	378	185	11	GO:0034702
GeneOntologyCellularComponent	voltage-gated calcium channel complex	CACNA1E RYR1 CACNG2 CATSPERG	7.25e-04	46	185	4	GO:0005891
Domain	K_chnl_inward-rec_Kir_N	KCNJ2 KCNJ12 KCNJ18	8.95e-07	3	181	3	IPR013673
Domain	IRK_N	KCNJ2 KCNJ12 KCNJ18	8.95e-07	3	181	3	PF08466
Domain	K_chnl_inward-rec_Kir2.2	KCNJ12 KCNJ18	9.34e-05	2	181	2	IPR003272
Domain	Ryanodine_rcpt	RYR1 RYR2	2.78e-04	3	181	2	IPR003032
Domain	Ryanrecept_TM4-6	RYR1 RYR2	2.78e-04	3	181	2	IPR009460
Domain	RyR	RYR1 RYR2	2.78e-04	3	181	2	PF02026
Domain	RR_TM4-6	RYR1 RYR2	2.78e-04	3	181	2	PF06459
Domain	Ryan_recept	RYR1 RYR2	2.78e-04	3	181	2	IPR013333
Domain	VWF_type-D	TECTA MUC4 MUC5AC	4.57e-04	16	181	3	IPR001846
Domain	VWFD	TECTA MUC4 MUC5AC	4.57e-04	16	181	3	PS51233
Domain	IRK	KCNJ2 KCNJ12 KCNJ18	4.57e-04	16	181	3	PF01007
Domain	AT_hook	AHCTF1 KMT2C KMT2A	4.57e-04	16	181	3	PF02178
Domain	VWD	TECTA MUC4 MUC5AC	4.57e-04	16	181	3	SM00216
Domain	K_chnl_inward-rec_Kir_cyto	KCNJ2 KCNJ12 KCNJ18	4.57e-04	16	181	3	IPR013518
Domain	-	KCNJ2 KCNJ12 KCNJ18	4.57e-04	16	181	3	2.60.40.1400
Domain	K_chnl_inward-rec_Kir	KCNJ2 KCNJ12 KCNJ18	4.57e-04	16	181	3	IPR016449
Domain	VWD	TECTA MUC4 MUC5AC	4.57e-04	16	181	3	PF00094
Domain	Olfact_rcpt	OR7G1 OR8J3 OR11G2 OR4A47 OR5B17 OR8J1 OR11H6 OR3A1 OR12D3 OR51B6 OR7G2 OR5AP2	4.66e-04	393	181	12	IPR000725
Domain	Leuzip_CREB	CREB3L1 ATF1	5.53e-04	4	181	2	IPR001630
Domain	cAMP_dep_PK_reg_su	PRKAR2A PRKAR2B	5.53e-04	4	181	2	IPR012198
Domain	Terpenoid_cyclase/PrenylTrfase	TCN2 C3 PZP	6.56e-04	18	181	3	IPR008930
Domain	HATPase_c	MORC4 TRAP1 MLH1	6.56e-04	18	181	3	SM00387
Domain	HATPase_c	MORC4 TRAP1 MLH1	7.74e-04	19	181	3	PF02518
Domain	-	MORC4 TRAP1 MLH1	9.04e-04	20	181	3	3.30.565.10
Domain	NIDO_dom	TECTA MUC4	9.16e-04	5	181	2	IPR003886
Domain	FYrich_C	KMT2C KMT2A	9.16e-04	5	181	2	IPR003889
Domain	FYrich_N	KMT2C KMT2A	9.16e-04	5	181	2	IPR003888
Domain	FYRC	KMT2C KMT2A	9.16e-04	5	181	2	SM00542
Domain	FYRN	KMT2C KMT2A	9.16e-04	5	181	2	SM00541
Domain	NIDO	TECTA MUC4	9.16e-04	5	181	2	SM00539
Domain	Znf_FCS	PHC2 PHC3	9.16e-04	5	181	2	IPR012313
Domain	NIDO	TECTA MUC4	9.16e-04	5	181	2	PF06119
Domain	NIDO	TECTA MUC4	9.16e-04	5	181	2	PS51220
Domain	FYRN	KMT2C KMT2A	9.16e-04	5	181	2	PF05964
Domain	FYRC	KMT2C KMT2A	9.16e-04	5	181	2	PF05965
Domain	FYRC	KMT2C KMT2A	9.16e-04	5	181	2	PS51543
Domain	FYRN	KMT2C KMT2A	9.16e-04	5	181	2	PS51542
Domain	HATPase_C	MORC4 TRAP1 MLH1	1.05e-03	21	181	3	IPR003594
Domain	RIH_assoc-dom	RYR1 RYR2	1.37e-03	6	181	2	IPR013662
Domain	-	AP1G1 AP3B2	1.37e-03	6	181	2	2.60.40.1230
Domain	ZF_FCS	PHC2 PHC3	1.37e-03	6	181	2	PS51024
Domain	Ins145_P3_rec	RYR1 RYR2	1.37e-03	6	181	2	PF08709
Domain	RIIa	PRKAR2A PRKAR2B	1.37e-03	6	181	2	SM00394
Domain	RIH_assoc	RYR1 RYR2	1.37e-03	6	181	2	PF08454
Domain	RIH_dom	RYR1 RYR2	1.37e-03	6	181	2	IPR000699
Domain	Ins145_P3_rcpt	RYR1 RYR2	1.37e-03	6	181	2	IPR014821
Domain	Clathrin_g-adaptin_app	AP1G1 AP3B2	1.37e-03	6	181	2	IPR008153
Domain	Ryanodine_recept-rel	RYR1 RYR2	1.37e-03	6	181	2	IPR015925
Domain	-	RYR1 RYR2	1.37e-03	6	181	2	1.25.10.30
Domain	RYDR_ITPR	RYR1 RYR2	1.37e-03	6	181	2	PF01365
Domain	Filament_head	NEFM NEFL	1.90e-03	7	181	2	PF04732
Domain	RIIa	PRKAR2A PRKAR2B	1.90e-03	7	181	2	PF02197
Domain	Intermed_filament_DNA-bd	NEFM NEFL	1.90e-03	7	181	2	IPR006821
Pubmed	A central chaperone-like role for 14-3-3 proteins in human cells.	PLK2 SORBS2 HIVEP1 EMC1 DSG2 MYCBP2 CEP85L ARHGEF5 PPP1R12A COBLL1 SPECC1 PABIR2 NHSL1 DLC1 SBF1 LMO7 RBM14 DOCK7 KMT2A FGD6 WNK3	9.51e-09	861	187	21	36931259
Pubmed	Ex vivo Quantitative Proteomic Analysis of Serotonin Transporter Interactome: Network Impact of the SERT Ala56 Coding Variant.	CACNA1E GAK SORBS2 BMP2K VPS13C PPP1R12A GDAP1 SPECC1 ARPC4 NEFM NEFL SBF1 AP3B2 PRKAR2A	1.01e-07	430	187	14	32581705
Pubmed	Fine localization of Nefl and Nef3 and its exclusion as candidate gene for lens rupture 2(lr2).	DOCK5 NEFM NEFL	1.53e-07	3	187	3	15297702
Pubmed	The consequences of disrupting cardiac inwardly rectifying K(+) current (I(K1)) as revealed by the targeted deletion of the murine Kir2.1 and Kir2.2 genes.	KCNJ2 KCNJ12 KCNJ18	1.53e-07	3	187	3	11410627
Pubmed	Targeted disruption of Kir2.1 and Kir2.2 genes reveals the essential role of the inwardly rectifying K(+) current in K(+)-mediated vasodilation.	KCNJ2 KCNJ12 KCNJ18	1.53e-07	3	187	3	10904001
Pubmed	Low-affinity spermine block mediating outward currents through Kir2.1 and Kir2.2 inward rectifier potassium channels.	KCNJ2 KCNJ12 KCNJ18	1.53e-07	3	187	3	17640933
Pubmed	SRCAP complex promotes lung cancer progression by reprograming the oncogenic transcription of Hippo-YAP/TAZ signaling pathway.	GAK DSG2 MYCBP2 RBM10 PPP1R12A AHCTF1 BCOR NEFM KMT2C LMO7 DOCK7 KMT2A PRKDC TAF2 WIPI2	3.33e-07	549	187	15	38280479
Pubmed	Different evolutionary processes shaped the mouse and human olfactory receptor gene families.	OR7G1 OR8J3 OR11G2 OR4A47 OR8J1 OR11H6 OR3A1 OR12D3 OR51B6 OR7G2 OR4A4P OR5AP2	3.63e-07	340	187	12	11875048
Pubmed	The olfactory receptor gene superfamily of the mouse.	OR7G1 OR8J3 OR11G2 OR4A47 OR8J1 OR11H6 OR3A1 OR12D3 OR51B6 OR7G2 OR4A4P OR5AP2	3.63e-07	340	187	12	11802173
Pubmed	A unified nomenclature for vertebrate olfactory receptors.	OR7G1 OR8J3 OR11G2 OR4A47 OR8J1 OR11H6 OR3A1 OR12D3 OR51B6 OR7G2 OR4A4P OR5AP2	3.98e-07	343	187	12	32295537
Pubmed	Odorant receptor expressed sequence tags demonstrate olfactory expression of over 400 genes, extensive alternate splicing and unequal expression levels.	OR7G1 OR8J3 OR11G2 OR4A47 OR8J1 OR11H6 OR3A1 OR12D3 OR51B6 OR7G2 OR4A4P OR5AP2	4.37e-07	346	187	12	14611657
Pubmed	Identifications of novel host cell factors that interact with the receptor-binding domain of the SARS-CoV-2 spike protein.	SECISBP2L EMC1 ARHGEF5 POLE COLGALT1 RCC2 DOCK5 SBF1 AP1G1 RBM14 DOCK7 MLH1 KMT2A PLCB3 PZP ZBED1	5.33e-07	650	187	16	38777146
Pubmed	Functional characterization of inward rectifier potassium ion channel in murine fetal ventricular cardiomyocytes.	KCNJ2 KCNJ12 KCNJ18	6.09e-07	4	187	3	20798526
Pubmed	Spatiotemporal profile of postsynaptic interactomes integrates components of complex brain disorders.	GPRASP1 CACNA1E SORBS2 MYCBP2 PPP1R12A CCT4 BCOR GRM5 ARPC4 FAM81A CACNG2 ZNF462 NEFM NEFL SBF1 DOCK7 PRKAR2A PRKAR2B WNK3	1.25e-06	963	187	19	28671696
Pubmed	The RNA-mediated estrogen receptor α interactome of hormone-dependent human breast cancer cell nuclei.	EMC1 BMP2K DSG2 PPP1R12A AHCTF1 CCT4 BCOR SPECC1 RCC2 PHC2 MSL2 KMT2C PHC3 URB1 TRMT10C SBF1 AP1G1 MLH1 RBM5 PRKAR2A KMT2A ATF1 TAF2 ZNF687	1.87e-06	1497	187	24	31527615
Pubmed	The inward rectifier potassium channel family.	KCNJ2 KCNJ12 KCNJ18	3.02e-06	6	187	3	7580148
Pubmed	Impact of WIN site inhibitor on the WDR5 interactome.	SPECC1 ZNF462 KMT2C SBF1 KMT2A	3.47e-06	43	187	5	33472061
Pubmed	New interaction partners for Nek4.1 and Nek4.2 isoforms: from the DNA damage response to RNA splicing.	OR7G1 RBM10 AHCTF1 CCT4 TECTA CERT1 PHC2 ZNF462 DOCK5 TRAP1 AP3B2 PRKDC SPAG17	4.69e-06	513	187	13	25798074
Pubmed	The ATG5 interactome links clathrin-mediated vesicular trafficking with the autophagosome assembly machinery.	GAK COBLL1 CCT4 COLGALT1 DOCK5 TRMT10C SBF1 AP1G1 AGL	4.73e-06	230	187	9	35449600
Pubmed	Genomic organization of the region spanning D14Mit262 and D14Mit86 on mouse chromosome 14 and exclusion of Adam28 and Adamdec1 as the cataract-causing gene, lr2.	DOCK5 NEFM NEFL	8.40e-06	8	187	3	17268172
Pubmed	Kelch Domain of Gigaxonin Interacts with Intermediate Filament Proteins Affected in Giant Axonal Neuropathy.	MXRA5 RBM10 CCT4 NEFM NEFL TRAP1 TENM3 MUC5AC	8.44e-06	187	187	8	26460568
Pubmed	A Degradation Motif in STAU1 Defines a Novel Family of Proteins Involved in Inflammation.	BMP2K MYCBP2 RBMS2 PPP1R12A DYSF ARPC4 TRAP1 URB1 SBF1 LMO7 RBM14 DOCK7 TAF2 KIF18B NNT	9.78e-06	724	187	15	36232890
Pubmed	An organelle-specific protein landscape identifies novel diseases and molecular mechanisms.	SECISBP2L MYCBP2 PPP1R12A COBLL1 CLOCK ARPC4 PABIR2 DOCK5 NEFM NEFL TRAP1 LMO7 RTL9 EIF2B4 RBM14 DOCK7 C3 KIF18B METTL25 FGD6 MUC5AC	9.81e-06	1321	187	21	27173435
Pubmed	Deregulation of the protocadherin gene FAT1 alters muscle shapes: implications for the pathogenesis of facioscapulohumeral dystrophy.	ACTN2 RYR1 NEFM	1.25e-05	9	187	3	23785297
Pubmed	Tumor suppressor BAP1 nuclear import is governed by transportin-1.	MYCBP2 RBM10 PPP1R12A CCT4 MORC4 PABIR2 RCC2 NEFM NEFL TRAP1 LMO7 AGL EIF2B4 RBM14 DOCK7 PRKAR2A PRKAR2B PRKDC ALDH9A1	1.55e-05	1149	187	19	35446349
Pubmed	A High-Density Map for Navigating the Human Polycomb Complexome.	HIVEP1 MYCBP2 CCT4 MORC4 BCOR SPECC1 PHC2 ZNF462 KMT2C PHC3 RBM14 KMT2A	1.70e-05	495	187	12	27705803
Pubmed	Voltage-dependent conformational changes of Kv1.3 channels activate cell proliferation.	SPECC1 RYR1 KMT2C AP3B2 DOCK7 KMT2A TRPM1 DNAH5	1.83e-05	208	187	8	33230847
Pubmed	Targeted proteomic analysis of 14-3-3 sigma, a p53 effector commonly silenced in cancer.	SORBS2 MYCBP2 ARHGEF5 LMO7 ERRFI1 TNS4	1.96e-05	102	187	6	15778465
Pubmed	A Human Tyrosine Phosphatase Interactome Mapped by Proteomic Profiling.	GAK EMC1 DSG2 POLE CCT4 EYA3 RCC2 TRMT10C SBF1 PTPRM AGL EIF2B4 C3 TTC13 DUSP10 PRKDC ALDH9A1	2.27e-05	974	187	17	28675297
Pubmed	Synaptic GAP and GEF Complexes Cluster Proteins Essential for GTP Signaling.	CACNA1E SORBS2 GRM5 FAM81A CACNG2 NEFM NEFL PRKAR2A PRKAR2B	2.34e-05	281	187	9	28706196
Pubmed	H4K20me0 recognition by BRCA1-BARD1 directs homologous recombination to sister chromatids.	RBM10 AHCTF1 BCOR CLOCK RCC2 PHC2 MSL2 DOCK5 KMT2C PHC3 URB1 LMO7 RBM14 RBM5 KMT2A ATF1 PRKDC KIF18B ZNF687 FOXC1	2.41e-05	1294	187	20	30804502
Pubmed	The in vivo Interaction Landscape of Histones H3.1 and H3.3.	HIVEP1 ARHGEF5 AHCTF1 EYA3 BCOR ZNF462 PHC3 RBAK MLH1 KMT2A TAF2 KIF18B FOXC1	2.81e-05	608	187	13	36089195
Pubmed	Direct and specific activation of human inward rectifier K+ channels by membrane phosphatidylinositol 4,5-bisphosphate.	KCNJ2 KCNJ12	2.88e-05	2	187	2	20921230
Pubmed	Compromised regulation of the collecting duct ENaC activity in mice lacking AT1a receptor.	AGTR1 SCNN1A	2.88e-05	2	187	2	29574718
Pubmed	Ryanodine receptor oligomeric interaction: identification of a putative binding region.	RYR1 RYR2	2.88e-05	2	187	2	14722100
Pubmed	Structural and functional interactions within ryanodine receptor.	RYR1 RYR2	2.88e-05	2	187	2	26009179
Pubmed	Autoregulation of RBM10 and cross-regulation of RBM10/RBM5 via alternative splicing-coupled nonsense-mediated decay.	RBM10 RBM5	2.88e-05	2	187	2	28586478
Pubmed	Ryanodine receptors in human pancreatic beta cells: localization and effects on insulin secretion.	RYR1 RYR2	2.88e-05	2	187	2	15033925
Pubmed	Functional consequences of Kir2.1/Kir2.2 subunit heteromerization.	KCNJ2 KCNJ12	2.88e-05	2	187	2	20676672
Pubmed	Partial dysferlin reconstitution by adult murine mesoangioblasts is sufficient for full functional recovery in a murine model of dysferlinopathy.	DYSF PRKDC	2.88e-05	2	187	2	21364666
Pubmed	Dual-mode phospholipid regulation of human inward rectifying potassium channels.	KCNJ2 KCNJ12	2.88e-05	2	187	2	21281576
Pubmed	Identification and characterisation of novel mammalian homologues of Drosophila polyhomeoticpermits new insights into relationships between members of the polyhomeotic family.	PHC2 PHC3	2.88e-05	2	187	2	12384788
Pubmed	Absence of the mid-sized neurofilament subunit decreases axonal calibers, levels of light neurofilament (NF-L), and neurofilament content.	NEFM NEFL	2.88e-05	2	187	2	9566972
Pubmed	Mouse angiotensin receptor genes Agtr1a and Agtr1b map to chromosomes 13 and 3.	AGTR1 FOXC1	2.88e-05	2	187	2	9096120
Pubmed	Crystal structures of wild type and disease mutant forms of the ryanodine receptor SPRY2 domain.	RYR1 RYR2	2.88e-05	2	187	2	25370123
Pubmed	Structure and evolutionary origin of the gene encoding mouse NF-M, the middle-molecular-mass neurofilament protein.	NEFM NEFL	2.88e-05	2	187	2	3036526
Pubmed	MUC4 and MUC5AC are highly specific tumour-associated mucins in biliary tract cancer.	MUC4 MUC5AC	2.88e-05	2	187	2	18475301
Pubmed	Skeletal and cardiac ryanodine receptors exhibit different responses to Ca2+ overload and luminal ca2+.	RYR1 RYR2	2.88e-05	2	187	2	17259277
Pubmed	Structure and Function of the Human Ryanodine Receptors and Their Association with Myopathies-Present State, Challenges, and Perspectives.	RYR1 RYR2	2.88e-05	2	187	2	32899693
Pubmed	β-Arrestin regulation of myosin light chain phosphorylation promotes AT1aR-mediated cell contraction and migration.	PPP1R12A AGTR1	2.88e-05	2	187	2	24255721
Pubmed	Immune responses to Pneumocystis murina are robust in healthy mice but largely absent in CD40 ligand-deficient mice.	CD40LG PRKDC	2.88e-05	2	187	2	18467653
Pubmed	Role of Kir2.2 in hypercapnic ventilatory response during postnatal development of mouse.	KCNJ12 KCNJ18	2.88e-05	2	187	2	15705530
Pubmed	Structural Basis for Differences in Dynamics Induced by Leu Versus Ile Residues in the CD Loop of Kir Channels.	KCNJ2 KCNJ12	2.88e-05	2	187	2	26520451
Pubmed	Truncation of the Mll gene in exon 5 by gene targeting leads to early preimplantation lethality of homozygous embryos.	NEFM KMT2A	2.88e-05	2	187	2	11536426
Pubmed	Alteration of ocular surface mucins in MUC5AC-DTA transgenic mice.	MUC4 MUC5AC	2.88e-05	2	187	2	19158956
Pubmed	RBM10 promotes transformation-associated processes in small cell lung cancer and is directly regulated by RBM5.	RBM10 RBM5	2.88e-05	2	187	2	28662214
Pubmed	Plasticity of KIR channels in human smooth muscle cells from internal thoracic artery.	KCNJ2 KCNJ12	2.88e-05	2	187	2	12598232
Pubmed	CD40 ligand increases complement C3 secretion by proximal tubular epithelial cells.	CD40LG C3	2.88e-05	2	187	2	15872081
Pubmed	Colorectal Cancer-Associated Genes Are Associated with Tooth Agenesis and May Have a Role in Tooth Development.	ATF1 DUSP10	2.88e-05	2	187	2	29445242
Pubmed	Regulation of Adipose Tissue Inflammation and Insulin Resistance by MAPK Phosphatase 5.	ABCC5 DUSP10	2.88e-05	2	187	2	25922079
Pubmed	Recent advances in understanding the ryanodine receptor calcium release channels and their role in calcium signalling.	RYR1 RYR2	2.88e-05	2	187	2	30542613
Pubmed	[Detection of level and mutation of neurofilament mRNA in Alzheimer's disease].	NEFM NEFL	2.88e-05	2	187	2	12133495
Pubmed	Ryanodine receptors are expressed and functionally active in mouse spermatogenic cells and their inhibition interferes with spermatogonial differentiation.	RYR1 RYR2	2.88e-05	2	187	2	15280431
Pubmed	Expression of the ryanodine receptor isoforms in immune cells.	RYR1 RYR2	2.88e-05	2	187	2	11673493
Pubmed	B-lymphocytes from malignant hyperthermia-susceptible patients have an increased sensitivity to skeletal muscle ryanodine receptor activators.	RYR1 RYR2	2.88e-05	2	187	2	11673462
Pubmed	Absence of T and B lymphocytes modulates dystrophic features in dysferlin deficient animal model.	DYSF PRKDC	2.88e-05	2	187	2	22465227
Pubmed	The clinical and genetic features in a cohort of mainland Chinese patients with thyrotoxic periodic paralysis.	KCNJ2 KCNJ18	2.88e-05	2	187	2	25885757
Pubmed	Cancers from Novel Pole-Mutant Mouse Models Provide Insights into Polymerase-Mediated Hypermutagenesis and Immune Checkpoint Blockade.	POLE MLH1	2.88e-05	2	187	2	32938641
Pubmed	Thermodynamics of calmodulin binding to cardiac and skeletal muscle ryanodine receptor ion channels.	RYR1 RYR2	2.88e-05	2	187	2	18618700
Pubmed	PKA phosphorylation dissociates FKBP12.6 from the calcium release channel (ryanodine receptor): defective regulation in failing hearts.	RYR2 PRKAR2A PRKAR2B	3.25e-05	12	187	3	10830164
Pubmed	Large-scale proteomics and phosphoproteomics of urinary exosomes.	TEKT3 MXRA5 VPS13C AHCTF1 COBLL1 TTYH3 CUBN TECTA DYSF ARPC4 GFRA1 RYR1 FAM151A CAPN7 PRKAR2A ALDH9A1 ALK	3.84e-05	1016	187	17	19056867
Pubmed	A systems-wide screen identifies substrates of the SCFβTrCP ubiquitin ligase.	RBM10 POLE BCOR SBF1 DOCK7 RBM5 FLCN FOXC1	3.98e-05	232	187	8	25515538
Pubmed	Viral genetic determinants of nonprogressive HIV type 1 subtype C infection in antiretroviral drug-naive children.	AP1G1 PRKAR2A PRKAR2B	4.20e-05	13	187	3	19895210
Pubmed	TNF-α inhibits glucocorticoid receptor-induced gene expression by reshaping the GR nuclear cofactor profile.	SATB2 MXRA5 HIVEP1 POLE MORC4 BCOR RYR1 RYR2 RNF123 FLCN TAF2 ZNF687 FHIP2B	4.61e-05	638	187	13	31182584
Pubmed	Odorant and vomeronasal receptor genes in two mouse genome assemblies.	OR7G1 OR8J3 OR11G2 OR8J1 OR7G2	5.08e-05	74	187	5	15081110
Pubmed	Dynamic Protein Interactions of the Polycomb Repressive Complex 2 during Differentiation of Pluripotent Cells.	POLE AHCTF1 MORC4 FAM81A ZNF462 NEFL KMT2C RTL9 KMT2A TAF2 MUC4	5.17e-05	469	187	11	27634302
Pubmed	Combinatorial targeting of a chromatin complex comprising Dot1L, menin and the tyrosine kinase BAZ1B reveals a new therapeutic vulnerability of endocrine therapy-resistant breast cancer.	DSG2 RBM10 PPP1R12A AHCTF1 CCT4 ARPC4 ZNF462 URB1 LMO7 RBM14 RBM5 KMT2A PRKDC ZNF687 FOXC1	5.92e-05	847	187	15	35850772
Pubmed	Transcription and Signaling Regulators in Developing Neuronal Subtypes of Mouse and Human Enteric Nervous System.	SATB2 GFRA1 ZNF462 PTPRM ARNT2 SLITRK6 ALK UNC5D	6.91e-05	251	187	8	29031500
Pubmed	SETD1A Methyltransferase Is Physically and Functionally Linked to the DNA Damage Repair Protein RAD18.	RBM10 SPECC1 RCC2 KMT2C RBM5 KMT2A PRKDC TAF2	6.91e-05	251	187	8	31076518
Pubmed	Differential physiological roles for BIN1 isoforms in skeletal muscle development, function and regeneration.	ACTN2 DYSF RYR1	8.14e-05	16	187	3	32994313
Pubmed	MECP2 directly interacts with RNA polymerase II to modulate transcription in human neurons.	SORBS2 EMC1 MYCBP2 RBM10 RCC2 PHC2 ZNF462 NEFM NEFL TRMT10C SBF1 RBM14 DOCK7 RBM5 PRKDC PZP CATSPERG	8.29e-05	1082	187	17	38697112
Pubmed	Fyn Regulates Binding Partners of Cyclic-AMP Dependent Protein Kinase A.	CCT4 TRAP1 PRKAR2A PRKAR2B PRKDC	8.31e-05	82	187	5	30274258
Pubmed	Large-scale characterization of HeLa cell nuclear phosphoproteins.	SORBS2 HIVEP1 MYCBP2 RBM10 BCOR PHC2 PHC3 LMO7 RBM14 KMT2A PLCB3 PRKDC UNC5D ZNF687	8.40e-05	774	187	14	15302935
Pubmed	Type 1 and type 3 ryanodine receptors are selectively involved in muscarinic antinociception in mice: an antisense study.	RYR1 RYR2	8.60e-05	3	187	2	18403125
Pubmed	FAP is critical for ovarian cancer cell survival by sustaining NF-κB activation through recruitment of PRKDC in lipid rafts.	FAP PRKDC	8.60e-05	3	187	2	36494579
Pubmed	Differential polyamine sensitivity in inwardly rectifying Kir2 potassium channels.	KCNJ2 KCNJ12	8.60e-05	3	187	2	16373386
Pubmed	Neurofilaments and motor neuron disease.	NEFM NEFL	8.60e-05	3	187	2	17708953
Pubmed	Remodeling of the enhancer landscape during macrophage activation is coupled to enhancer transcription.	KMT2C KMT2A	8.60e-05	3	187	2	23932714
Pubmed	Dopamine D1 receptor signaling system regulates ryanodine receptor expression in ethanol physical dependence.	RYR1 RYR2	8.60e-05	3	187	2	23278119
Pubmed	Expression of NF-L and NF-M in fibroblasts reveals coassembly of neurofilament and vimentin subunits.	NEFM NEFL	8.60e-05	3	187	2	2493000
Pubmed	Methylation and expression of neurofilament genes in tissues and in cell lines of the mouse.	NEFM NEFL	8.60e-05	3	187	2	8510499
Pubmed	Mutations in neurofilament genes are not a significant primary cause of non-SOD1-mediated amyotrophic lateral sclerosis.	NEFM NEFL	8.60e-05	3	187	2	16084104
Pubmed	Haploinsufficiency for either one of the type-II regulatory subunits of protein kinase A improves the bone phenotype of Prkar1a+/- mice.	PRKAR2A PRKAR2B	8.60e-05	3	187	2	26246497
Pubmed	Heterogeneous gene expression and functional activity of ryanodine receptors in resistance and conduit pulmonary as well as mesenteric artery smooth muscle cells.	RYR1 RYR2	8.60e-05	3	187	2	18434746
Pubmed	Neurofilament-deficient axons and perikaryal aggregates in viable transgenic mice expressing a neurofilament-beta-galactosidase fusion protein.	NEFM NEFL	8.60e-05	3	187	2	8110465
Pubmed	SPRY domains in ryanodine receptors (Ca(2+)-release channels).	RYR1 RYR2	8.60e-05	3	187	2	9204703
Pubmed	Heteromerization of Kir2.x potassium channels contributes to the phenotype of Andersen's syndrome.	KCNJ2 KCNJ12	8.60e-05	3	187	2	12032359
Pubmed	Ryanodine receptors are expressed in epidermal keratinocytes and associated with keratinocyte differentiation and epidermal permeability barrier homeostasis.	RYR1 RYR2	8.60e-05	3	187	2	21881589
Pubmed	Hematopoietic neoplasms in Prkar2a-deficient mice.	PRKAR2A PRKAR2B	8.60e-05	3	187	2	26608815
Pubmed	Estrogen receptors modulate striatal metabotropic receptor type 5 in intact and MPTP male mice model of Parkinson's disease.	ESR2 GRM5	8.60e-05	3	187	2	26873133
Interaction	FEV interactions	SATB2 HIVEP1 MORC4 BCOR ZNF462 KMT2C PHC3 KMT2A ATF1 TAF2 FOXC1	1.78e-06	203	176	11	int:FEV
Interaction	YWHAZ interactions	SORBS2 HIVEP1 DSG2 MYCBP2 CEP85L ARHGEF5 PPP1R12A ESR2 COBLL1 BCOR SPECC1 PABIR2 MSL2 NEFM NHSL1 NEFL SBF1 LMO7 ERRFI1 RBM14 DOCK7 PRKAR2A KMT2A PRKAR2B C3 ALDH9A1 FGD6 GP1BA	1.09e-05	1319	176	28	int:YWHAZ
Interaction	PPP1CB interactions	SORBS2 BMP2K MYCBP2 PPP1R12A ESR2 CCT4 ACTN2 CLOCK SPECC1 ARPC4 RYR2 LMO7 PRKAR2A TAF2 KIF18B	1.65e-05	469	176	15	int:PPP1CB
Interaction	CHMP4B interactions	SORBS2 DSG2 MYCBP2 PPP1R12A AHCTF1 ACTN2 SPECC1 RCC2 IGSF10 NEFL TRAP1 URB1 RNF123 LMO7 CAPN7 RBM14 PRKAR2A PRKDC TAF2	2.10e-05	727	176	19	int:CHMP4B
Interaction	WWTR1 interactions	GAK DSG2 MYCBP2 RBM10 PPP1R12A AHCTF1 BCOR CLOCK NEFM LMO7 ARNT2 DOCK7 KMT2A WIPI2	2.14e-05	422	176	14	int:WWTR1
Interaction	SLC6A4 interactions	CACNA1E GAK SORBS2 BMP2K VPS13C PPP1R12A GDAP1 SPECC1 ARPC4 NEFM NEFL SBF1 AP3B2 PRKAR2A	3.13e-05	437	176	14	int:SLC6A4
Interaction	NFIX interactions	SATB2 HIVEP1 ESR2 ACTN2 BCOR KMT2C MLH1 KMT2A NNT FOXC1	3.21e-05	227	176	10	int:NFIX
Interaction	SOX2 interactions	SATB2 HIVEP1 RBMS2 PPP1R12A CCT4 KCTD21 BCOR CLOCK ARPC4 RYR1 PHC2 ZNF462 KMT2C PHC3 TRAP1 EIF2B4 RBM14 DOCK7 RBM5 KMT2A PRKAR2B C3 ATF1 TNS4 TAF2 ALDH9A1 ZNF687 FOXC1	4.25e-05	1422	176	28	int:SOX2
Interaction	ATG5 interactions	GAK VPS13C ESR2 COBLL1 CCT4 COLGALT1 DOCK5 TRMT10C SBF1 AP1G1 AGL WIPI2	5.20e-05	344	176	12	int:ATG5
Interaction	TBR1 interactions	SATB2 HIVEP1 MYCBP2 MORC4 BCOR KMT2C RNF123	6.10e-05	113	176	7	int:TBR1
Cytoband	12q15-q21	TRHDE PPP1R12A	4.94e-05	3	187	2	12q15-q21
GeneFamily	Ryanodine receptors\|Protein phosphatase 1 regulatory subunits	RYR1 RYR2	1.39e-04	3	124	2	287
GeneFamily	Potassium voltage-gated channel subfamily J	KCNJ2 KCNJ12 KCNJ18	1.65e-04	16	124	3	276
GeneFamily	CD molecules\|Mucins	MUC17 MUC4 MUC5AC	3.83e-04	21	124	3	648
GeneFamily	Intermediate filaments Type IV	NEFM NEFL	6.87e-04	6	124	2	611
GeneFamily	C3 and PZP like, alpha-2-macroglobulin domain containing	C3 PZP	1.63e-03	9	124	2	1234
ToppCell	Fetal_brain-organoid_Tanaka_cellReport-GW23-Neuronal-Intermediate\|GW23 / Sample Type, Dataset, Time_group, and Cell type.	TRHDE MXRA5 DSG2 RCC2 GFRA1 URB1 SBF1 TENM3 ERRFI1 PLCB3 SPATA4	9.33e-10	200	187	11	fe772d98c461c973dfc082e1fc50117c27ced804
ToppCell	facs-Brain_Non-Myeloid-Striatum-24m-Epithelial-nan\|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation	TRHDE DSG2 FNDC1 TSBP1 SCNN1A SCUBE3 C3 SPAG17 DNAH5	8.92e-08	184	187	9	264e14aa1859cfc0ed5fb40e97ea189aed9ef4a5
ToppCell	facs-Brain_Non-Myeloid-Striatum-24m-Epithelial\|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation	TRHDE DSG2 FNDC1 TSBP1 SCNN1A SCUBE3 C3 SPAG17 DNAH5	8.92e-08	184	187	9	d7eccbd21c480d907fdc8eff2bf5ae22ae452221
ToppCell	facs-Brain_Non-Myeloid-Striatum-24m-Epithelial-neuroepithelial_cell\|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation	TRHDE DSG2 FNDC1 TSBP1 SCNN1A SCUBE3 C3 SPAG17 DNAH5	8.92e-08	184	187	9	22010cfe0428ebfa40952cc1a1a12ad3d25b35c9
ToppCell	NS-critical-d_16-33-Epithelial-Secretory\|d_16-33 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined)	GABRE DSG2 PTGES CREB3L1 SCNN1A C3 TNS4 SLITRK6 MUC5AC	1.60e-07	197	187	9	a72047b7428c0d4aaf016c1ac23dc30919260fd8
ToppCell	10x3'2.3-week_14-16-Mesenchymal_osteo-stroma-osteoblast_precursor\|week_14-16 / cell types per 3 fetal stages;per 3',per 5'	SATB2 MXRA5 PTGES GFRA1 FAP FNDC1 LMO7 ERRFI1 FOXC1	1.67e-07	198	187	9	9d61483b0decac2fe90045b3474843360b2c49b3
ToppCell	NS-critical-LOC-Epithelial-Secretory_LYPD2\|LOC / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined)	GABRE PTGES CREB3L1 LMO7 SCNN1A PRKAR2B C3 MUC4 MUC5AC	1.67e-07	198	187	9	4a481e1edb80b950c823ed926842cd5132cfb27f
ToppCell	COVID-19-Heart-Neuronal\|COVID-19 / Disease (COVID-19 only), tissue and cell type	GFRA1 DOCK5 DLC1 TENM3 ABCA6 IL1RAPL2 DIP2C ALK	5.78e-07	168	187	8	88c2c574f428c2502b5fe099bd73b0758f668ef6
ToppCell	facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	TRHDE PKD1L2 PKHD1L1 RYR2 GUCY2F SPAG17 DNAH5 UNC5D	1.15e-06	184	187	8	2cbed6462fea2622871bb7e49b0df3d984239281
ToppCell	facs-Thymus-Thymus_Epithelium-18m-Lymphocytic\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	TRHDE PKD1L2 PKHD1L1 RYR2 GUCY2F SPAG17 DNAH5 UNC5D	1.15e-06	184	187	8	ea7a7e2bac46d4d2c31a5d576b38a032b5335062
ToppCell	facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	TRHDE PKD1L2 PKHD1L1 RYR2 GUCY2F SPAG17 DNAH5 UNC5D	1.15e-06	184	187	8	2b19a8c5f823e00812908b23e66bb4e563278aff
ToppCell	droplet-Bladder-nan-24m-Endothelial-nan\|Bladder / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CACNA1E SORBS2 HTR2B GPR146 FAP PTPRM TSBP1 KCNJ2	1.20e-06	185	187	8	90caab8d9361a541c5d5121c97c3f1cdffeeae4a
ToppCell	droplet-Heart-nan-3m-Endothelial-endocardial_cell\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CACNA1E DSG2 CERT1 PKHD1L1 PABIR2 ZNF462 FOXC1 KLHL4	1.40e-06	189	187	8	8e583ec4df0f5b79ce5211cc99ecd8616d180bde
ToppCell	droplet-Heart-nan-3m-Endothelial-endocardial_endothelial_cells\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CACNA1E DSG2 CERT1 PKHD1L1 PABIR2 ZNF462 FOXC1 KLHL4	1.40e-06	189	187	8	fb2253b8463d08b3d28e952a31a23dea2c2d986b
ToppCell	3'-Airway_Nasal-Epithelial-Epithelial_transtional-secretory-nasal_mucosa_goblet_cell-Goblet_(nasal)-Goblet_(nasal)_L.0.2.0.2\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	GABRE SORBS2 PTGES CREB3L1 LMO7 PRKAR2B MUC4 MUC5AC	1.46e-06	190	187	8	6ea9fa08bd97bedcb21d3654467e7f8dd74c8fd0
ToppCell	LPS-antiTNF-Stromal_mesenchymal\|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	TRHDE PTGES GFRA1 RYR2 IGSF10 TENM3 ABCA6 PZP	1.71e-06	194	187	8	6e13549f697f7478b34fe71f7dd9d63c5d3db22e
ToppCell	356C-Epithelial_cells-Epithelial-A_(AT2)\|356C / Donor, Lineage, Cell class and subclass (all cells)	SECISBP2L COBLL1 CREB3L1 NHSL1 MFSD2A DLC1 LMO7 C3	1.84e-06	196	187	8	93a5d9b8bcff7d07596ef1f4f2b74f043835fc69
ToppCell	ASK440-Epithelial-Type_2\|ASK440 / Donor, Lineage and Cell class of Lung cells from Dropseq	SECISBP2L CREB3L1 NHSL1 MFSD2A DLC1 LMO7 SCNN1A C3	1.84e-06	196	187	8	754b4202b617165c6994a0b5a9b1e486dccdd44d
ToppCell	356C-Epithelial_cells-Epithelial-A_(AT2)-\|356C / Donor, Lineage, Cell class and subclass (all cells)	SECISBP2L COBLL1 CREB3L1 NHSL1 MFSD2A DLC1 LMO7 C3	1.84e-06	196	187	8	4715f19f844e7244fc4bc446cba7c8088c600fc3
ToppCell	10x5'v1-week_12-13-Mesenchymal_osteo-stroma-osteoblast_precursor\|week_12-13 / cell types per 3 fetal stages;per 3',per 5'	SATB2 MXRA5 PTGES CREB3L1 GFRA1 FNDC1 ERRFI1 SCUBE3	1.91e-06	197	187	8	2f72fd9a5b6d62c24a95ed2246194ea7458c0f12
ToppCell	ASK452-Epithelial-Transformed_epithelium\|ASK452 / Donor, Lineage and Cell class of Lung cells from Dropseq	PLK2 COBLL1 PKHD1L1 RYR2 MFSD2A LMO7 ERRFI1 C3	1.91e-06	197	187	8	b22a79a5922c865a360e2afc5506a08a512fa76a
ToppCell	moderate-Epithelial-unknown_epithelial\|moderate / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls	PLK2 ACTN2 NEFM SCNN1A CATSPERG MUC4 FOXC1	1.96e-06	138	187	7	afefa8233c67aa744e939156bc538449bf6bd05b
ToppCell	AT2_cells\|World / lung cells shred on cell class, cell subclass, sample id	SECISBP2L COBLL1 CREB3L1 MFSD2A LMO7 TMEM245 SCNN1A C3	1.99e-06	198	187	8	92c569c3b8a9fca2d4682cbf77ee8149bcc0a80a
ToppCell	moderate-Epithelial-Secretory\|moderate / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls	DSG2 PTGES CREB3L1 LMO7 SCNN1A C3 MUC4 MUC5AC	1.99e-06	198	187	8	7d96d7105a849c7280ce87bd76ce130ac47384fd
ToppCell	5'-Airway_Nasal-Epithelial-Epithelial_transtional-secretory-club_cell-Club_(nasal)\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	MXRA5 DSG2 PTGES CREB3L1 RYR1 AGL PRKAR2B TNS4	2.06e-06	199	187	8	fbd39d34636137d1b877dd8815d58f124990136b
ToppCell	NS-control-d_0-4-Epithelial-Secretory\|d_0-4 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined)	DSG2 MYCBP2 COBLL1 CREB3L1 SCNN1A PRKAR2B C3 SLITRK6	2.06e-06	199	187	8	32bdfff40fd442b88489c8b0f79af3927a51a03c
ToppCell	Biopsy_Control_(H.)-Epithelial-AT2\|Biopsy_Control_(H.) / Sample group, Lineage and Cell type	COBLL1 CREB3L1 MFSD2A DLC1 LMO7 TMEM245 SCNN1A C3	2.06e-06	199	187	8	5323d49d3be980605b3e609b7f03bddba6e50e8a
ToppCell	5'-Airway_Nasal-Epithelial-Epithelial_transtional-secretory-club_cell\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	MXRA5 DSG2 PTGES CREB3L1 RYR1 AGL PRKAR2B TNS4	2.06e-06	199	187	8	6977f939ddbc47d4921f36c0a61a205259fe1284
ToppCell	control-Epithelial-Secretory\|Epithelial / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls	DSG2 MYCBP2 COBLL1 CREB3L1 SCNN1A PRKAR2B C3 SLITRK6	2.06e-06	199	187	8	3d01f90ffd271ca00129192787e4921bdca7e01e
ToppCell	LPS_IL1RA-Mesenchymal_fibroblastic-Fibroblasts-Activated_MatrixFB\|LPS_IL1RA / Treatment groups by lineage, cell group, cell type	MXRA5 RYR2 IGSF10 TENM3 ABCA6 C3 PZP SLC25A28	2.06e-06	199	187	8	8b86c69aaf60feff53aa782559cfece7342a23de
ToppCell	control-Epithelial-Secretory\|control / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls	DSG2 MYCBP2 COBLL1 CREB3L1 SCNN1A PRKAR2B C3 SLITRK6	2.06e-06	199	187	8	262e5b8a52c8ddb0b47048c786e8bdb7158e1b9a
ToppCell	moderate-Epithelial-Secretory-diff\|moderate / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls	PTGES CREB3L1 LMO7 SCNN1A PRKAR2B C3 MUC4 MUC5AC	2.14e-06	200	187	8	6f29ef9dcf126c5c19386f6aa9a20c38a2c8ccc8
ToppCell	distal-Epithelial\|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed)	DSG2 CREB3L1 MFSD2A LMO7 SCNN1A C3 DNAH5 MUC4	2.14e-06	200	187	8	0a97080f694738bb882787cee21b91a4d5757b7a
ToppCell	Biopsy_Other_PF-Epithelial\|Biopsy_Other_PF / Sample group, Lineage and Cell type	DSG2 CREB3L1 MFSD2A LMO7 SCNN1A C3 DNAH5 MUC4	2.14e-06	200	187	8	1ef4d5ae698fa721e0f510bf0d918bd8d3b00591
ToppCell	Parenchymal-10x5prime-Epithelial\|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations	DSG2 CREB3L1 MFSD2A LMO7 ERRFI1 SCNN1A C3 MUC4	2.14e-06	200	187	8	4e5b6cb014d9bcb58e13c7511c86c43e27c496e4
ToppCell	Biopsy_IPF-Epithelial-MUC5B+\|Biopsy_IPF / Sample group, Lineage and Cell type	PLK2 PTGES CREB3L1 SCNN1A C3 TNS4 MUC4 MUC5AC	2.14e-06	200	187	8	f0a6747f6d37ec6d261bd649ac678c39cca5e4c8
ToppCell	Control_saline-Mesenchymal_fibroblastic-Fibroblasts-MatrixFB\|Control_saline / Treatment groups by lineage, cell group, cell type	TRHDE ACTN2 CREB3L1 IGSF10 FAP ABCA6 SLITRK6 PZP	2.14e-06	200	187	8	bd8cf33502adea320e91ca2af14e1911d88ad374
ToppCell	LV-16._Neuronal\|World / Chamber and Cluster_Paper	DOCK5 DLC1 TENM3 ABCA6 IL1RAPL2 SLITRK6 ALK	6.40e-06	165	187	7	6ed52cb756d21addf46c7f6c457458b01339fe04
ToppCell	Control-Myeloid-Mast\|Control / Disease state, Lineage and Cell class	BMP2K COBLL1 SPECC1 ZNF462 DIP2C DUSP10 PZP	7.78e-06	170	187	7	9a14deb7f7cd4a49c217eba4023f7bf1dec6c902
ToppCell	renal_papilla_nuclei-Hypertensive_with+without-CKD-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Proximal_Tubule_Epithelial_Cell\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	ACTN2 GRM5 SLCO5A1 TENM3 AGTR1 DUSP10 UNC5D	1.05e-05	178	187	7	a0ab20c588e7d43d0320d4779d9ab95c1c86e297
ToppCell	Control-Stromal_mesenchymal-Matrix_Fibroblast-MatrixFB\|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	TRHDE PTGES ACTN2 CREB3L1 RYR2 IGSF10 ABCA6	1.13e-05	180	187	7	08ae0f5d95c45feba68ad99788f7af7ff4c979af
ToppCell	Primary_Visual_cortex_(V1C)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_C_(IT_L4_RORB)-Exc_L4_RORB_CACNG5\|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	TRHDE COBLL1 GFRA1 ZNF462 PTPRM IL1RAPL2 ADGRE5	1.30e-05	184	187	7	658f2e522055e88c92bc482a845c40f8f5f1a8e3
ToppCell	droplet-Fat-Scat-21m-Mesenchymal-Cd34+\|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation	PI16 CREB3L1 NHSL1 NEFL FAP FNDC1 ERRFI1	1.35e-05	185	187	7	01bbe1e09f9ccae837a03ea2cdd168fa10800942
ToppCell	primary_visual_cortex-Neuronal-glutamatergic_neuron\|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype	CACNA1E SATB2 FAM81A RYR2 NEFM NEFL TENM3	1.40e-05	186	187	7	56c139e679d640ea901ead657a8e8887e0fca098
ToppCell	COPD-Myeloid-Mast\|COPD / Disease state, Lineage and Cell class	BMP2K COBLL1 ZNF462 DIP2C DUSP10 PZP WNK3	1.40e-05	186	187	7	def6f0f284acc2154738574c8c5d3d2a5ef1f208
ToppCell	facs-Skin-Telogen-3m-Epithelial-basal_cell_of_epidermis\|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	PLK2 DSG2 PTGES NHSL1 ERRFI1 SLITRK6 MAPKBP1	1.44e-05	187	187	7	9c1013720c248ef201d010806b6e7ad24205e8ee
ToppCell	Control-Epithelial_cells\|Control / group, cell type (main and fine annotations)	SORBS2 DOCK5 DLC1 LMO7 ERRFI1 SCNN1A DNAH5	1.50e-05	188	187	7	707ebf76cc6fb600b2f07793cf4ea9482c0de79d
ToppCell	facs-Skin-Telogen-3m-Epithelial-Basal_IFE\|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	PLK2 DSG2 PTGES FAM81A NHSL1 ERRFI1 MAPKBP1	1.50e-05	188	187	7	8cc927b4c51d982fdafa04dc7393617ad9bb220e
ToppCell	renal_cortex_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	SATB2 COBLL1 LMO7 ARNT2 SCNN1A SPAG17 DNAH5	1.60e-05	190	187	7	3fc9e18c7441c0ae8cda65753cc42d0520f4e116
ToppCell	COPD-Myeloid-Mast\|Myeloid / Disease state, Lineage and Cell class	BMP2K COBLL1 ZNF462 DIP2C DUSP10 PZP WNK3	1.60e-05	190	187	7	379dbac19110b76079a7a53209569e060a852acb
ToppCell	PCW_10-12-Mesenchymal-Mesenchymal_fibroblastic-mes_adventitial_fibro_(10)\|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung	MXRA5 SORBS2 PI16 CREB3L1 TENM3 C3 KLHL4	1.60e-05	190	187	7	4f775ee24b14733f06ae40b45f2dc1a0f0df0705
ToppCell	COVID-19-Epithelial_cells-Airway_goblet\|COVID-19 / group, cell type (main and fine annotations)	IL1RAPL2 LMO7 SCNN1A TNS4 DNAH5 MUC4 MUC5AC	1.60e-05	190	187	7	51ca9ef4df3220487152fcf684147730637c7cc1
ToppCell	renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Intermediate_tubule_epithelial_cell\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	TRHDE SATB2 COBLL1 ZNF462 DNAH5 UNC5D FOXC1	1.66e-05	191	187	7	d0e9afe7b6334dd515d3e68892efdc76347a55e5
ToppCell	3'-Airway_Nasal-Epithelial-Epithelial_transtional-secretory-nasal_mucosa_goblet_cell-Goblet_(nasal)-Goblet_(nasal)_L.0.2.0.0\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	PTGES CREB3L1 LMO7 SCNN1A PRKAR2B MUC4 MUC5AC	1.66e-05	191	187	7	cd709bbcd320373468ea7f058ee5fda8a067b5d0
ToppCell	3'-Airway_Nasal-Epithelial-Epithelial_transtional-secretory-nasal_mucosa_goblet_cell\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	PTGES CREB3L1 LMO7 SCNN1A PRKAR2B MUC4 MUC5AC	1.66e-05	191	187	7	14851529025cfc2b665f71ebad04150ec543da7a
ToppCell	10x3'2.3-week_12-13-Mesenchymal_osteo-stroma-osteoblast_precursor\|week_12-13 / cell types per 3 fetal stages;per 3',per 5'	SATB2 MXRA5 PTGES CREB3L1 GFRA1 FNDC1 FOXC1	1.66e-05	191	187	7	98b907f8fa024cf32e462323b782c5a371327bbd
ToppCell	ASK454-Epithelial-Secretory\|ASK454 / Donor, Lineage and Cell class of Lung cells from Dropseq	EYA3 MFSD2A TRAP1 URB1 RNF123 MUC4 NNT	1.66e-05	191	187	7	c63c781e7e93265e591cf494cb4ce8ed797c24fb
ToppCell	3'-Airway_Nasal-Epithelial-Epithelial_transtional-secretory-nasal_mucosa_goblet_cell-Goblet_(nasal)\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	PTGES CREB3L1 LMO7 SCNN1A PRKAR2B MUC4 MUC5AC	1.66e-05	191	187	7	e14b22e882ac92acf8c8b6ee997ef8e799c7a8d5
ToppCell	droplet-Limb_Muscle-MUSCLE-30m-Mesenchymal-mesenchymal_stem_cell\|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	MYCBP2 VPS13C IGSF10 FAP FNDC1 ABCA6 C3	1.71e-05	192	187	7	11088878043a6ff95ba1970361256a82e434b80a
ToppCell	Adult-Epithelial-alveolar_epithelial_cell_type_2-D122\|Adult / Lineage, Cell type, age group and donor	SECISBP2L COBLL1 CREB3L1 MFSD2A DLC1 SCNN1A DNAH5	1.71e-05	192	187	7	06013a07e3a873b1d1c0451643c528593ac32a9c
ToppCell	Adult-Epithelial\|Adult / Lineage, Cell type, age group and donor	SORBS2 COBLL1 MFSD2A DLC1 LMO7 SCNN1A DNAH5	1.71e-05	192	187	7	efb962a5fd3b9bdfd8cf8d13c435e29c8271713e
ToppCell	COVID-19-lung-Secretory\|COVID-19 / Disease (COVID-19 only), tissue and cell type	LMO7 ERRFI1 SCNN1A TNS4 DNAH5 MUC4 MUC5AC	1.71e-05	192	187	7	59261098ccb52306f837f632ebaea45b90ad30fe
ToppCell	Children_(3_yrs)-Mesenchymal-matrix_fibroblast_2_cell-D046\|Children_(3_yrs) / Lineage, Cell type, age group and donor	MXRA5 PI16 GFRA1 IGSF10 FAP ABCA6 C3	1.71e-05	192	187	7	e0f4e4470a71bfa81d9dcd8594e5f82aafc24f81
ToppCell	renal_cortex_nuclei-Adult_normal_reference-Epithelial\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	TRHDE COBLL1 CUBN LMO7 ERRFI1 SCNN1A DIP2C	1.77e-05	193	187	7	3866667dd221612589ae50f5c52f73a183a49ce6
ToppCell	AT2_cells-Donor_02\|World / lung cells shred on cell class, cell subclass, sample id	SECISBP2L COBLL1 CREB3L1 MFSD2A TMEM245 SCNN1A C3	1.77e-05	193	187	7	8187f976fd2d11fad3286690f1a046e894772220
ToppCell	356C-Epithelial_cells\|356C / Donor, Lineage, Cell class and subclass (all cells)	CREB3L1 NHSL1 MFSD2A DLC1 LMO7 SCNN1A C3	1.89e-05	195	187	7	d913d0a6c4797d9a873ddea6f340c3f152da1cf3
ToppCell	(7)_Epithelial-A_(AT2)\|World / Lung cell shreds - cell class (v4) and cell subclass (v4)	SECISBP2L COBLL1 CREB3L1 NHSL1 MFSD2A LMO7 C3	1.89e-05	195	187	7	c9a6c65ee18d83bf34a4713d306a6e30db1325c2
ToppCell	cellseq-Epithelial-Epithelial_Alveolar-AT2-AT2\|cellseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	SECISBP2L COBLL1 CREB3L1 MFSD2A DLC1 TMEM245 C3	1.89e-05	195	187	7	6867f9c56ea27a17c8c4099aae0d79903c3748a5
ToppCell	AT2_cells-Donor_06\|World / lung cells shred on cell class, cell subclass, sample id	SECISBP2L COBLL1 CREB3L1 MFSD2A TMEM245 SCNN1A C3	1.89e-05	195	187	7	b0cea3f4e59635913d243612f2e8cf4c7b34e726
ToppCell	3'-Airway_Nasal-Epithelial-Epithelial_transtional-secretory-club_cell-Club_(nasal)-Club_(nasal)_L.0.2.3.0\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	PTGES CREB3L1 SCNN1A PRKAR2B C3 MUC4 MUC5AC	1.89e-05	195	187	7	3f8ed20ad17afe1545e574e5ca5fe33c3704c7f3
ToppCell	cellseq-Epithelial-Epithelial_Alveolar-AT2\|cellseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	SECISBP2L COBLL1 CREB3L1 MFSD2A DLC1 TMEM245 C3	1.89e-05	195	187	7	955a0a7244cd7eaf006a39e1bd03333baf6f30a4
ToppCell	nucseq-Epithelial\|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	SORBS2 COBLL1 DLC1 PTPRM LMO7 SCNN1A DNAH5	1.89e-05	195	187	7	9406866f99555198a9be311fbd65751b70f35446
ToppCell	COVID-19-Epithelial-Club,_Basal_cells\|COVID-19 / Condition, Lineage and Cell class	PTGES CREB3L1 SCNN1A C3 SLITRK6 MUC4 MUC5AC	1.96e-05	196	187	7	dd32046067d93b9484cfbf1d7826a436a3d9f0e9
ToppCell	renal_medulla_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	SPECC1 DLC1 TENM3 ABCA6 AGTR1 PRKAR2B ADGRE5	1.96e-05	196	187	7	2b36b9a40fe415917afccff99ad9c3474e087d0d
ToppCell	cellseq-Epithelial-Epithelial_Alveolar\|cellseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	SECISBP2L COBLL1 MFSD2A DLC1 LMO7 TMEM245 C3	1.96e-05	196	187	7	a7cbe66ebd8931ef2b8ff26a42afce0ad1c48f17
ToppCell	3'-Broncho-tracheal-Epithelial-Epithelial_transtional-secretory-nasal_mucosa_goblet_cell-Goblet_(nasal)-Goblet_(nasal)_L.0.2.0.0\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	DSG2 PTGES CREB3L1 LMO7 SCNN1A MUC4 MUC5AC	1.96e-05	196	187	7	60ea673ed887fe3890c5cf4ff4165384b76d7361
ToppCell	356C-Epithelial_cells-Epithelial-B_(AT2)-\|356C / Donor, Lineage, Cell class and subclass (all cells)	DSG2 NHSL1 MFSD2A DLC1 LMO7 SCNN1A C3	2.02e-05	197	187	7	06ed8f293d4ee89f14dc2f43d6cae93bbc02508a
ToppCell	LPS_anti-TNF-Mesenchymal_fibroblastic-Fibroblasts-Activated_MatrixFB\|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type	TRHDE MXRA5 RYR2 IGSF10 TENM3 ABCA6 PZP	2.02e-05	197	187	7	fdb92985f7df0c280b87d3e43c2394e70786a2c7
ToppCell	COVID-19-Epithelial-Club,_Basal_cells\|Epithelial / Condition, Lineage and Cell class	PTGES CREB3L1 RYR1 C3 TNS4 SLITRK6 MUC5AC	2.02e-05	197	187	7	78ed2810e5a765327e7a6da0ca5d4854bf7a0b6f
ToppCell	Tracheal-NucSeq-Stromal-Fibroblastic-Fibro_myofibroblast\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	TRHDE PI16 ADGRG4 GFRA1 FAP DLC1 ABCA6	2.02e-05	197	187	7	0dd71e399f253787fa546a7e90c5373180b89ffd
ToppCell	renal_medulla_nuclei-CKD+DKD_normotensive-Mesenchymal\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	SPECC1 DLC1 TENM3 ABCA6 AGTR1 PRKAR2B ADGRE5	2.02e-05	197	187	7	80e153790cef37b743e22a7370ff5b3a6abf147d
ToppCell	Transverse-(5)_Dendritic_cell-(53)_Lymphoid_DC\|Transverse / shred on region, Cell_type, and subtype	BMP2K DSG2 SPECC1 RYR1 SLCO5A1 ABCA6 FGD6	2.02e-05	197	187	7	15b87fd3906d7388c271d30d0c64b1bcc490801c
ToppCell	356C-Epithelial_cells-Epithelial-B_(AT2)\|356C / Donor, Lineage, Cell class and subclass (all cells)	DSG2 NHSL1 MFSD2A DLC1 LMO7 SCNN1A C3	2.02e-05	197	187	7	c115d0a45545ed24259ad88872231bf4d4d389d2
ToppCell	ASK452-Epithelial-Transformed_epithelium\|Epithelial / Donor, Lineage and Cell class of Lung cells from Dropseq	PLK2 COBLL1 PKHD1L1 RYR2 DOCK5 MFSD2A C3	2.02e-05	197	187	7	e92757e988888347c74286cc42c262b03159b0b9
ToppCell	Transverse-Dendritic_cell-Lymphoid_DC\|Transverse / Region, Cell class and subclass	BMP2K DSG2 SPECC1 RYR1 SLCO5A1 ABCA6 FGD6	2.02e-05	197	187	7	a58af0ea82f76f2a7abac1f62629ff20d552fc63
ToppCell	BL-critical-LOC-Epithelial-Secretory_LYPD2\|LOC / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined)	SORBS2 CREB3L1 LMO7 SCNN1A PRKAR2B MUC4 MUC5AC	2.09e-05	198	187	7	484d16aaa601a1e11b871b0475dd01a2de1a29ce
ToppCell	distal-Epithelial-Club-2\|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed)	DSG2 PTGES LMO7 SCNN1A C3 DNAH5 MUC4	2.09e-05	198	187	7	77c7fa7626ea35cb50de9c2f2df637d22e77d3fe
ToppCell	10x3'2.3-week_14-16-Mesenchymal_adipo-stroma-adipo-CAR\|week_14-16 / cell types per 3 fetal stages;per 3',per 5'	MXRA5 PTGES GFRA1 FNDC1 DLC1 ERRFI1 FOXC1	2.09e-05	198	187	7	a8c21f4db6730d0aa05b61fbe72bf9f7571a9015
ToppCell	10x3'2.3-week_14-16-Mesenchymal_adipo-stroma\|week_14-16 / cell types per 3 fetal stages;per 3',per 5'	MXRA5 PTGES GFRA1 FNDC1 DLC1 ERRFI1 FOXC1	2.09e-05	198	187	7	8b68fc887e5ad0a59ea4d93dfd1edda67030f142
ToppCell	10x5'v1-week_14-16-Mesenchymal_osteo-stroma-osteoblast_precursor\|week_14-16 / cell types per 3 fetal stages;per 3',per 5'	SATB2 MXRA5 PTGES GFRA1 FNDC1 LMO7 ERRFI1	2.09e-05	198	187	7	bc9c9f2c87282b5ef8514773e065d2a6b5dde338
ToppCell	10x3'2.3-week_14-16-Mesenchymal_adipo\|week_14-16 / cell types per 3 fetal stages;per 3',per 5'	MXRA5 PTGES GFRA1 FNDC1 DLC1 ERRFI1 FOXC1	2.09e-05	198	187	7	4739b2e4ab141c66772e61686b45614a1839483e
ToppCell	Bronchial-NucSeq-Epithelial\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	SECISBP2L SORBS2 COBLL1 NHSL1 MFSD2A LMO7 SCNN1A	2.16e-05	199	187	7	5f7da3eab58ace6cddb3179a415cd839d5767958
ToppCell	Bronchial-NucSeq-Epithelial-Epi_alveolar\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	COBLL1 NHSL1 MFSD2A DLC1 PTPRM LMO7 SCNN1A	2.16e-05	199	187	7	725610310e5c5fd7120c0be9acb55bf152026ddd
ToppCell	Parenchymal-NucSeq-Epithelial-Epi_alveolar\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	COBLL1 DOCK5 NHSL1 MFSD2A DLC1 LMO7 SCNN1A	2.16e-05	199	187	7	8587bd98de7767a575088afbea07a1feb4516b9b
ToppCell	Bronchial-10x5prime-Stromal-Fibroblastic-Fibro_immune_recruiting\|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations	PTGES GFRA1 FNDC1 TENM3 FAM151A C3 GP1BA	2.16e-05	199	187	7	0cdbedf09ec72734b86ddab3fec562e066afed92
ToppCell	Biopsy_Other_PF-Epithelial-MUC5B+\|Biopsy_Other_PF / Sample group, Lineage and Cell type	PTGES LMO7 SCNN1A C3 TNS4 MUC4 MUC5AC	2.16e-05	199	187	7	afd0df242a93f176438309668a9487be1250d9ca
ToppCell	10x_3'_v2v3-Non-neoplastic-Vascular-Mural_cell-Scavenging_endothelial\|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	SORBS2 TCN2 RBMS2 MFSD2A PTPRM FGD6 FOXC1	2.16e-05	199	187	7	d95d78b2ebc9a20532466e4d4be579b4faf6776f
ToppCell	10x_3'_v2v3-Non-neoplastic-Vascular-Mural_cell-Scavenging_endothelial-F\|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	SORBS2 TCN2 RBMS2 MFSD2A PTPRM FGD6 FOXC1	2.16e-05	199	187	7	cdcfca94baba66e213cc3ffb0cfb4c75d6ab44ec
ToppCell	LPS_IL1RA-Mesenchymal_fibroblastic-Fibroblasts-MatrixFB\|LPS_IL1RA / Treatment groups by lineage, cell group, cell type	MYCBP2 ACTN2 RYR2 IGSF10 TENM3 ABCA6 PZP	2.16e-05	199	187	7	a7dd94b172c973a131a6792f8ccd9bfe44d984ac
ToppCell	ASK452-Epithelial\|ASK452 / Donor, Lineage and Cell class of Lung cells from Dropseq	DSG2 MFSD2A LMO7 ERRFI1 C3 SPAG17 DNAH5	2.16e-05	199	187	7	e8778d4d2bc7e15b4c7989a93e5808a76738df46
Disease	Colorectal Carcinoma	SATB2 TCN2 RBM10 POLE ESR2 MCF2L2 ABCC5 CUBN KMT2C DLC1 ABCA6 LMO7 MLH1 DIP2C FLCN TNS4 ACTL9 SPAG17 ABCD2 PZP	6.52e-09	702	173	20	C0009402
Disease	Colorectal Neoplasms	SATB2 TCN2 POLE ESR2 ABCC5 DLC1 ABCA6 MLH1 FLCN ABCD2	5.99e-06	277	173	10	C0009404
Disease	colorectal cancer (is_implicated_in)	RBM10 POLE ESR2 BCOR DLC1 MLH1 FLCN	7.59e-06	121	173	7	DOID:9256 (is_implicated_in)
Disease	Squamous cell carcinoma of lung	BMP2K GUCY2F PRKDC WNK3	3.61e-05	32	173	4	C0149782
Disease	apolipoprotein A 1 measurement	COBLL1 TSC22D2 GRM5 RFX4 CREB3L1 MSL2 DLC1 ABCA6 MUC17 EIF2B4 DOCK7 KMT2A ATF1 PLCB3 NNT OR4A4P	4.26e-05	848	173	16	EFO_0004614
Disease	congenital hypothyroidism (implicated_via_orthology)	TG NEFM NEFL	6.88e-05	14	173	3	DOID:0050328 (implicated_via_orthology)
Disease	Lung diseases	SCNN1A FLCN ADGRE5 PRKDC DNAH5	9.77e-05	78	173	5	C0024115
Disease	congenital myopathy 1A (implicated_via_orthology)	RYR1 RYR2	1.02e-04	3	173	2	DOID:3529 (implicated_via_orthology)
Disease	vitamin B12 deficiency (implicated_via_orthology)	TCN2 CD40LG	1.02e-04	3	173	2	DOID:0050731 (implicated_via_orthology)
Disease	malignant hyperthermia (implicated_via_orthology)	RYR1 RYR2	1.02e-04	3	173	2	DOID:8545 (implicated_via_orthology)
Disease	mosaic loss of chromosome Y measurement	CENPN RNF19B TSC22D2 ZNF462 TRMT10C	1.10e-04	80	173	5	EFO_0007783
Disease	Clear Cell Sarcoma of Soft Tissue	BCOR ATF1	2.03e-04	4	173	2	C0206651
Disease	Adenocarcinoma of large intestine	POLE DLC1 MLH1 FLCN PRKDC	2.60e-04	96	173	5	C1319315
Disease	triglycerides:total lipids ratio, low density lipoprotein cholesterol measurement	ANKRD31 COBLL1 MSL2 ABCA6 DOCK7 PLCB3	2.65e-04	150	173	6	EFO_0004611, EFO_0020947
Disease	Anemia, Megaloblastic	TCN2 CUBN	3.38e-04	5	173	2	C0002888
Disease	mucinous adenocarcinoma (is_marker_for)	MUC4 MUC5AC	3.38e-04	5	173	2	DOID:3030 (is_marker_for)
Disease	calcium measurement	SECISBP2L ANKRD31 ATXN7L1 ESR2 COBLL1 MSL2 TRMT10C ABCA6 RTL9 EIF2B4 PRKAR2B FHIP2B	3.54e-04	628	173	12	EFO_0004838
Disease	free cholesterol to total lipids in medium VLDL percentage	ANKRD31 COBLL1 ABCA6 DOCK7	3.54e-04	57	173	4	EFO_0022284
Disease	Sjogren's syndrome (is_marker_for)	NEFL CD40LG MUC5AC	3.66e-04	24	173	3	DOID:12894 (is_marker_for)
Disease	triglycerides to total lipids in small LDL percentage	COBLL1 ABCA6 DOCK7 PLCB3	4.04e-04	59	173	4	EFO_0022337
Disease	RS-10-hydroxywarfarin to RS-warfarin ratio measurement	TRHDE CEP85L MCF2L2 DYSF WIPI2	4.87e-04	110	173	5	EFO_0803335
Disease	triglycerides to total lipids in IDL percentage	COBLL1 CERT1 ABCA6 DOCK7	5.19e-04	63	173	4	EFO_0022329
Disease	triglycerides to total lipids in medium VLDL percentage	ANKRD31 COBLL1 ABCA6 DOCK7	5.19e-04	63	173	4	EFO_0022335
Disease	cholesterol to total lipids in medium VLDL percentage	ANKRD31 COBLL1 ABCA6 DOCK7	5.19e-04	63	173	4	EFO_0022239
Disease	cholesterol to total lipids in very small VLDL percentage	COBLL1 CERT1 ABCA6 DOCK7	6.56e-04	67	173	4	EFO_0022245
Disease	adrenoleukodystrophy (implicated_via_orthology)	ACSBG2 ABCD2	7.04e-04	7	173	2	DOID:10588 (implicated_via_orthology)
Disease	biliary tract benign neoplasm (is_marker_for)	MUC4 MUC5AC	7.04e-04	7	173	2	DOID:0050625 (is_marker_for)
Disease	Huntington disease, disease progression measurement	GFRA1 PTPRM TRPM1	7.16e-04	30	173	3	EFO_0008336, MONDO_0007739
Disease	triglycerides to total lipids in very small VLDL percentage	COBLL1 CERT1 ABCA6 DOCK7	7.33e-04	69	173	4	EFO_0022341
Disease	cholesteryl esters to total lipids in very small VLDL percentage	COBLL1 CERT1 ABCA6 DOCK7	8.17e-04	71	173	4	EFO_0022259
Disease	generalized anxiety disorder (implicated_via_orthology)	HTR2B ZNF462	9.35e-04	8	173	2	DOID:14320 (implicated_via_orthology)
Disease	endometrial cancer (implicated_via_orthology)	POLE ERRFI1	9.35e-04	8	173	2	DOID:1380 (implicated_via_orthology)
Disease	common bile duct neoplasm (is_marker_for)	MUC4 MUC5AC	9.35e-04	8	173	2	DOID:4608 (is_marker_for)
Disease	depressive symptom measurement	TRHDE CACNA1E HIVEP1 ESR2 POM121L2 GRM5 PRKAR2A KMT2A UNC5D	9.69e-04	426	173	9	EFO_0007006
Disease	free cholesterol to total lipids in small VLDL percentage	ANKRD31 COBLL1 ABCA6 DOCK7	1.00e-03	75	173	4	EFO_0022287
Disease	Alzheimer's disease (is_implicated_in)	ESR2 CLOCK NEFM AGTR1 C3	1.11e-03	132	173	5	DOID:10652 (is_implicated_in)
Disease	low density lipoprotein cholesterol measurement, free cholesterol:total lipids ratio	PLK2 COBLL1 TSC22D2 ABCA6 DOCK7 PLCB3	1.20e-03	200	173	6	EFO_0004611, EFO_0020945
Disease	glycine measurement	CENPN COBLL1 PKD1L2 GRM5 MSL2	1.31e-03	137	173	5	EFO_0009767
Disease	triglycerides:total lipids ratio, high density lipoprotein cholesterol measurement	PLK2 COBLL1 TSC22D2 MSL2 DOCK7 PLCB3	1.40e-03	206	173	6	EFO_0004612, EFO_0020947
Disease	Adenocarcinoma of lung (disorder)	PLK2 GUCY2F EIF2B4 MLH1 PRKDC ALK	1.40e-03	206	173	6	C0152013
Disease	response to risperidone	DOCK5 NEFL TRPM1	1.44e-03	38	173	3	GO_0097336
Disease	Kunitz-type protease inhibitor 2 measurement	RYR1 CATSPERG	1.49e-03	10	173	2	EFO_0008200
Disease	arrhythmogenic right ventricular cardiomyopathy (is_implicated_in)	ACTN2 RYR2	1.49e-03	10	173	2	DOID:0050431 (is_implicated_in)
Disease	susceptibility to influenza measurement	NEFM NEFL	1.49e-03	10	173	2	EFO_0803537
Disease	plasma trimethylamine N-oxide measurement	CEP85L EYA3	1.49e-03	10	173	2	EFO_0005691
Disease	VENTRICULAR TACHYCARDIA, CATECHOLAMINERGIC POLYMORPHIC, 1 (disorder)	RYR2 KCNJ2	1.49e-03	10	173	2	C1631597
Disease	Drug toxicity	PLK2 HTR2B TCN2 C3	1.53e-03	84	173	4	C0013221
Disease	Adverse reaction to drug	PLK2 HTR2B TCN2 C3	1.53e-03	84	173	4	C0041755
Disease	Graves' disease (is_implicated_in)	ESR2 TG CD40LG	1.55e-03	39	173	3	DOID:12361 (is_implicated_in)
Disease	cholesterol:total lipids ratio, low density lipoprotein cholesterol measurement	ANKRD31 COBLL1 MSL2 DOCK7 PLCB3	1.63e-03	144	173	5	EFO_0004611, EFO_0020943
Disease	platelet component distribution width	BMP2K COBLL1 ABCC5 TTYH3 CUBN DOCK5 DLC1 DOCK7 MLH1 ADGRE5 FGD6 GP1BA	1.73e-03	755	173	12	EFO_0007984
Disease	triglyceride measurement, phospholipid measurement	PLK2 COBLL1 TSC22D2 DOCK7 PLCB3	1.73e-03	146	173	5	EFO_0004530, EFO_0004639
Disease	Carcinoma, Transitional Cell	ESR2 KMT2C KMT2A	1.79e-03	41	173	3	C0007138
Disease	Tachycardia, Ventricular	RYR2 KCNJ2	1.82e-03	11	173	2	C0042514
Disease	Conventional (Clear Cell) Renal Cell Carcinoma	RYR1 FLCN MUC4 ALK WNK3	1.84e-03	148	173	5	C0279702
Disease	Charcot-Marie-Tooth disease	GDAP1 NEFL SBF1	1.92e-03	42	173	3	cv:C0007959
Disease	very low density lipoprotein cholesterol measurement, cholesterol:total lipids ratio	ANKRD31 COBLL1 CERT1 ABCA6 DOCK7 PLCB3	2.04e-03	222	173	6	EFO_0008317, EFO_0020943
Disease	free cholesterol to total lipids in very small VLDL percentage	CERT1 ABCA6 DOCK7	2.06e-03	43	173	3	EFO_0022290
Disease	triglyceride measurement, very low density lipoprotein cholesterol measurement	PLK2 COBLL1 TSC22D2 CERT1 DOCK7 PLCB3	2.13e-03	224	173	6	EFO_0004530, EFO_0008317
Disease	red blood cell density measurement	HIVEP1 BMP2K ESR2 COBLL1 SPECC1 PHC2 TG ZNF462 KCNJ12 PLCB3 SLC25A28 MUC4 WIPI2	2.14e-03	880	173	13	EFO_0007978
Disease	diabetic angiopathy (is_marker_for)	CD40LG GP1BA	2.17e-03	12	173	2	DOID:11713 (is_marker_for)
Disease	Charcot-Marie-Tooth disease (is_implicated_in)	GDAP1 NEFL	2.17e-03	12	173	2	DOID:10595 (is_implicated_in)
Disease	mismatch repair cancer syndrome (is_implicated_in)	POLE MLH1	2.17e-03	12	173	2	DOID:0112182 (is_implicated_in)
Disease	cholesterol in medium VLDL measurement	CERT1 ABCA6 DOCK7	2.20e-03	44	173	3	EFO_0022225
Disease	phospholipids:total lipids ratio	ANKRD31 COBLL1 CERT1 MSL2 ABCA6 DOCK7	2.28e-03	227	173	6	EFO_0020946
Disease	very low density lipoprotein cholesterol measurement, phospholipid measurement	PLK2 COBLL1 CERT1 ABCA6 DOCK7 PLCB3	2.38e-03	229	173	6	EFO_0004639, EFO_0008317
Disease	alcohol and nicotine codependence	HIVEP1 CAPN7	2.55e-03	13	173	2	EFO_0004776
Disease	rhinitis (biomarker_via_orthology)	C3 MUC5AC	2.55e-03	13	173	2	DOID:4483 (biomarker_via_orthology)
Disease	Charcot-Marie-Tooth disease type 4	GDAP1 SBF1	2.55e-03	13	173	2	cv:C4082197
Disease	pre-eclampsia (implicated_via_orthology)	CD40LG C3	2.55e-03	13	173	2	DOID:10591 (implicated_via_orthology)
Disease	free cholesterol in small VLDL measurement	CERT1 ABCA6 DOCK7	2.66e-03	47	173	3	EFO_0022272
Disease	free cholesterol in medium VLDL measurement	CERT1 ABCA6 DOCK7	2.66e-03	47	173	3	EFO_0022269
Disease	serum albumin measurement	HIVEP1 RBMS2 COBLL1 DYSF CLOCK MSL2 ABCA6 RTL9 EIF2B4 PRKAR2B	2.70e-03	592	173	10	EFO_0004535
Disease	low density lipoprotein cholesterol measurement, alcohol consumption measurement	COBLL1 CERT1 ABCA6 DOCK7	2.79e-03	99	173	4	EFO_0004611, EFO_0007878
Disease	sciatic neuropathy (biomarker_via_orthology)	GFRA1 NEFM NEFL C3	2.79e-03	99	173	4	DOID:11446 (biomarker_via_orthology)
Disease	coronary artery disease (is_implicated_in)	ESR2 CUBN AGTR1 CD40LG	2.89e-03	100	173	4	DOID:3393 (is_implicated_in)
Disease	very low density lipoprotein cholesterol measurement, free cholesterol:total lipids ratio	ANKRD31 COBLL1 CERT1 ABCA6 DOCK7 PLCB3	2.94e-03	239	173	6	EFO_0008317, EFO_0020945
Disease	Childhood Ataxia with Central Nervous System Hypomyelinization	TCN2 EIF2B4	2.97e-03	14	173	2	C1858991
Disease	trimethylamine-N-oxide measurement	CUBN TTC13	2.97e-03	14	173	2	EFO_0010541
Disease	wet macular degeneration	C3 FGD6	2.97e-03	14	173	2	EFO_0004683
Disease	sickle cell anemia (is_marker_for)	CD40LG C3	2.97e-03	14	173	2	DOID:10923 (is_marker_for)
Disease	cholesterol in medium LDL measurement	CERT1 ABCA6 DOCK7	2.99e-03	49	173	3	EFO_0022224
Disease	cholesteryl esters to total lipids in small VLDL percentage	ANKRD31 ABCA6 DOCK7	2.99e-03	49	173	3	EFO_0022256
Disease	pancreatic cancer (is_marker_for)	ABCC5 ADGRE5 MUC4 MUC5AC	3.00e-03	101	173	4	DOID:1793 (is_marker_for)
Disease	response to cisplatin	NHSL1 TRPM1 SLITRK6	3.36e-03	51	173	3	GO_0072718
Disease	phospholipids in very small VLDL measurement	CERT1 ABCA6 DOCK7	3.36e-03	51	173	3	EFO_0022300
Disease	cholesterol to total lipids in small VLDL percentage	ANKRD31 ABCA6 DOCK7	3.36e-03	51	173	3	EFO_0022242
Disease	BMI-adjusted leptin measurement	COBLL1 ACTL9	3.41e-03	15	173	2	EFO_0007793
Disease	phospholipids in medium VLDL measurement	CERT1 ABCA6 DOCK7	3.55e-03	52	173	3	EFO_0022154
Disease	phospholipids in IDL measurement	ANKRD31 ABCA6 DOCK7	3.55e-03	52	173	3	EFO_0022164
Disease	total lipids in medium LDL	CERT1 ABCA6 DOCK7	3.55e-03	52	173	3	EFO_0022180
Disease	Prostatic Neoplasms	TCN2 ARHGEF5 ESR2 KMT2C MLH1 KMT2A PRKDC ZBED1 MUC4 FOXC1	3.57e-03	616	173	10	C0033578
Disease	Malignant neoplasm of prostate	TCN2 ARHGEF5 ESR2 KMT2C MLH1 KMT2A PRKDC ZBED1 MUC4 FOXC1	3.57e-03	616	173	10	C0376358
Disease	human papilloma virus infection, oropharynx cancer	DYSF TENM3 ALDH9A1	3.74e-03	53	173	3	EFO_0001668, EFO_1001931
Disease	triglycerides to total lipids in very large VLDL percentage	ANKRD31 COBLL1 ABCA6	3.74e-03	53	173	3	EFO_0022340
Disease	cholesterol in small VLDL measurement	CERT1 ABCA6 DOCK7	3.74e-03	53	173	3	EFO_0022228
Disease	cholesteryl esters to total lipids in very large VLDL percentage	COBLL1 ABCA6 DOCK7	3.74e-03	53	173	3	EFO_0022258
Disease	remnant cholesterol measurement	ANKRD31 CERT1 ABCA6 DOCK7	3.81e-03	108	173	4	EFO_0010815
Disease	serum IgG glycosylation measurement	CACNA1E VPS13C TSC22D2 GFRA1 RYR2 SBF1 TENM3 EIF2B4 FLCN	3.86e-03	523	173	9	EFO_0005193
Disease	Neuralgia, Supraorbital	GRM5 GFRA1	3.89e-03	16	173	2	C0038870

Protein segments in the cluster

Peptide	Gene	Start	Entry
NLYRAQVSPTASDML	PI16	41	Q6UXB8
ATYLSLSNMPVETSV	TRHDE	296	Q9UKU6
NTPVSYRMAKTLVFS	ACSBG2	366	Q5FVE4
TYASISGISSMPSLR	CATSPERG	1116	Q6ZRH7
MALSYRVSELQSTIP	HTR2B	1	P41595
MSTGTFVVSQPLNYR	ALDH9A1	1	P49189
ADGVYTASQMPSRSL	CREB3L1	411	Q96BA8
RAPSNTSTLMKFYSL	nan	6	Q9N2J8
IRISSSNPYSTVTMD	ACTN2	591	P35609
SSMFIFSTTNPIRRA	CACNA1E	1131	Q15878
MIETYNQTSPRSAAT	CD40LG	1	P29965
MLTSYTLIQTATSRG	ABCD2	236	Q9UBJ2
YQMSSLPVNVTAFTS	ADGRG4	1511	Q8IZF6
STKMSTLSYRPSDNV	AGTR1	331	P30556
SYLMTQIPGTQTESR	ARHGEF5	426	Q12774
NSSSLMVVYTPISNL	ABCA6	71	Q8N139
TYISPSNTELTLMIQ	ADGRE5	351	P48960
RSPAMYVASQSVLSV	ACTL9	171	Q8TC94
QATRTMQALPYSTVG	C3	436	P01024
AVSPMQRHSTYSSVR	SPECC1	861	Q5M775
VSYTSSLPAQVGTIM	BMP2K	576	Q9NSY1
YMTVSSEFPAARLSN	BCOR	376	Q6W2J9
PSFTVMRQSSLTFQS	COBLL1	1061	Q53SF7
APISSRLTSSYIMTS	ATXN7L1	546	Q9ULK2
SMLTRYARTQFLSPT	AP3B2	241	Q13367
MLIRTSSFTFQNPYS	ARNT2	411	Q9HBZ2
TNTSRESTMYPKAVQ	RCC2	411	Q9P258
AANSQSYTIMSPAVL	RBM10	521	P98175
MTAQAASYRAQPSVS	RBM14	266	Q96PK6
LTISYTGNRPASNMV	PZP	1371	P20742
NRMLAQSALSPYLSS	RBMS2	271	Q15434
GNSSDMYTPLTTRRN	RFX4	696	Q33E94
SQSLTMAPYSSVSLV	FAM81A	16	Q8TBF8
TLAATTYQSEKPSVM	EYA3	231	Q99504
MGSVRTNRYSIVSSE	KCNJ2	1	P63252
SVLISNMSTSVTRGY	AP1G1	511	O43747
NMSTSVTRGYALTAI	AP1G1	516	O43747
PYSRSSSMSSIDLVS	CERT1	371	Q9Y5P4
NTLPSTEISMYTLSR	CACNG2	261	Q9Y698
GTSRESMQSSPRYLQ	ANKRD31	1826	Q8N7Z5
YQIPTENSMTARNTT	DSG2	1061	Q14126
QLSAESVSSLYNMVP	OVOS1	541	Q6IE37
EALLSSPSYSVTQMI	MUC4	576	Q99102
YISSTVPNMLVNILS	OR11H6	91	Q8NGC7
NIPQIAYSATSMDLS	GRM5	166	P41594
SSAGNIMPTTYISVT	KMT2C	806	Q8NEZ4
LNSSMYPLVTATQDA	ESR2	406	Q92731
PQIYSLSSSSMEVFN	KCTD21	131	Q4G0X4
MTAASRANPYSIVSS	KCNJ12	1	Q14500
SSRLPEFIVQTASYM	LDOC1	61	O95751
YKSHLMSTVRSPTAS	FLCN	561	Q8NFG4
MTSKSSESNIYSPLT	METTL25	346	Q8N6Q8
VSLKAANLTYMPSSS	DUSP10	51	Q9Y6W6
SYSALIAMAIQSAPL	FOXI2	106	Q6ZQN5
ASSRYSMRNRIQSSP	NHSL1	1511	Q5SYE7
LNVMTYLTSIPSVEA	MCF2L2	81	Q86YR7
LVSMASPAAATYLVQ	FHIP2B	271	Q86V87
NPLIYTLRNSEMTSA	OR4A47	281	Q6IF82
SPLRYTSILTNTQVM	OR51B6	126	Q9H340
RPLTYSTRMSQTVQR	OR3A1	131	P47881
LTVDSMIPAYATTRI	GDAP1	146	Q8TB36
RSYTTQLTMNVPFQA	SLC25A28	226	Q96A46
QMESTRVSASLPRSY	LMO7	886	Q8WWI1
VSTSNRAYMRNPSSS	LMO7	1551	Q8WWI1
AFQNYVPSSVTTMLS	GABRE	281	P78334
ALYPSLSTSMVSASV	MUC5AC	4746	P98088
RMATEQPQTLATYSV	POLE	446	Q07864
STYYNPSLKSRVTMS	IGHV4-28	76	A0A0C4DH34
DASYSSSVTPKMLVN	OR5AP2	76	Q8NGF4
ITLTSVDSRLQNPMY	OR8J3	46	Q8NGG0
YSRQNSLTQFMSIPS	EIF2B4	186	Q9UI10
MPAVLERLSRYNSTS	GTPBP8	16	Q8N3Z3
RTVMIAAISPSSLTY	KIF18B	321	Q86Y91
MNPVNATALYISASR	MSL2	1	Q9HCI7
SIMTALSPYASLAVN	RBM5	246	P52756
TSSSRMQQPQISVYS	PHC3	26	Q8NDX5
STSPTLTASQAQMYL	PHC3	161	Q8NDX5
NYVASMSTPRSTVGV	KLHL4	551	Q9C0H6
MLATPSISVYTNRIQ	PKD1L2	1061	Q7Z442
LQAVVSSMPRYADAS	SBF1	1246	O95248
FTYIRPASATSMIQD	OR12D3	256	Q9UGF7
PYTLRTRRNSTTIMS	PABIR2	41	Q7Z309
FSYSQIVTSVLRMPS	OR7G1	216	Q8NGA0
VPYSALTMFISTEQT	MFSD2A	176	Q8NA29
STDMTQPLSAYFINS	PLCB3	316	Q01970
PSVLLSNDSSRFYAM	ABCC5	1411	O15440
ITLTSVDSRLQTPMY	OR8J1	46	Q8NGP2
RNASAVPVFYSSMST	CUBN	3356	O60494
SYITSRIAVMSFPAE	GAK	411	O14976
RTISDSPMTNINYGT	IGSF10	826	Q6WRI0
QSRTGSIVLPYIMSS	DOCK5	1651	Q9H7D0
YATMARSAVRPASLN	DOCK7	876	Q96N67
DLTNNPTMIYTVSSF	CAPN7	266	Q9Y6W3
VMTPNYIDSSSLSVA	GFRA1	296	P56159
NPYTMAVAARVTAAT	GBA2	331	Q9HCG7
NSATISTMTPGQITY	DEFB129	126	Q9H1M3
STSPNRTYTQAMVEK	FAM151A	216	Q8WW52
MQARYSVSSPNSLGV	FOXC1	1	Q12948
YTASSRGMLPTALQN	FNDC1	1056	Q4ZHG4
TVNTASRMESTGLPY	GUCY2F	1006	P51841
RRSLVVQTSMDAYTP	DIP2C	116	Q9Y2E4
ETPMQVLTGSSRQSY	CEP85L	336	Q5SZL2
SQTPYAFTSSSMLRR	CENPN	156	Q96H22
VLMSAPATTASYIQL	BPIFB6	206	Q8NFQ5
TFSLATLMPYTRLTQ	GP1BA	61	P07359
SYQNPTTSSMAKISR	MAPKBP1	1246	O60336
PNSSYTFSSIARVRM	KLHDC7A	256	Q5VTJ3
LMYNTPRAATIVATS	PRKAR2A	211	P13861
LMYNTPRAATITATS	PRKAR2B	226	P31323
SPMRTGNTYSRNNVS	KMT2A	2211	Q03164
QQSSMKSPLYLVSRS	AHCTF1	1136	Q8WYP5
QSYIFPSSISAMEAT	EMC1	836	Q8N766
QIPFNVSSLVAMYST	GPR146	106	Q96CH1
TRAYFTSATMIIAIP	MT-CO1	301	P00395
TVVAPMLDSRAAYSN	COLGALT1	186	Q8NBJ5
LVMRKNSSPSSITTY	SCUBE3	861	Q8IX30
LNYKTNSESPSVTMV	SCNN1A	531	P37088
AYTISPSSVEDTMSL	RYR1	2141	P21817
YSPRAIDMSNVTLSR	RYR2	2821	Q92736
MTCLPLASTTQYSRA	DYSF	626	O75923
SATTPLMFQRTIESY	DNAH5	2621	Q8TE73
TMKTNTLSTSVPNSY	PTPRM	826	P28827
YVTSTVPSMLANFLS	OR11G2	111	Q8NGC1
NPLHYTTTMTTRVCA	OR5B17	126	Q8NGF7
VAATASPQSLMEYSS	NAP1L6P	21	A6NFF2
NPLIYTLRNSEMTSA	OR4A4P	281	Q8NGN8
TTSTNVVEPRMYLSC	MUC17	71	Q685J3
MQTSTYSDRRTPLTS	MUC17	2151	Q685J3
LIYSTSITLLPMSNN	MT-ND2	296	P03891
IGYTDLPSRMATQAS	NNT	371	Q13423
LPSRMATQASTLYSN	NNT	376	Q13423
ITPFRKTMSTASAYT	NNT	466	Q13423
NYPSSRVRTSFLENM	GPRASP1	1206	Q5JY77
TTYTVSGRMATAPIR	RTL9	1006	Q8NET4
MTAASRANPYSIVSL	KCNJ18	1	B7U540
TRAMAGSIISSYNPQ	RNF19B	566	Q6ZMZ0
NAASPTSVRQMALSY	SFXN2	136	Q96NB2
YLMVTTPATTTNTAD	SLITRK6	581	Q9H5Y7
TPMNSLATSVFSIAI	TSC22D2	631	O75157
YMLTIPTAASNISLA	TAF2	236	Q6P1X5
RTNYSTAQSTGLRLM	IL1RAPL2	61	Q9NP60
LSYTQITSCVLRMPS	OR7G2	216	Q8NG99
RLSTMSPRYLQSNSS	MORC4	31	Q8TE76
PLSQSMISSIVNSTY	SATB2	196	Q9UPW6
QALMVSGYLSSVITT	SLCO5A1	141	Q9H2Y9
VSQYSSLLSPMSVNA	CCT4	176	P50991
NFLPAISTMASSYRD	TEKT3	21	Q9BXF9
MKARQITNTRPLSYT	SECISBP2L	506	Q93073
TTVTLPMIFNSSYLR	MYCBP2	4141	O75592
ASTSYLPSQVTEMFN	WIPI2	301	Q9Y4P8
RSVTYTLAQLPCASM	PTGES	126	O14684
GSNSSRMYFTQTLLP	MLH1	336	P40692
SMSSRLSIYDNVPGS	DLC1	871	Q96QB1
NIDPITMAYSLNSSA	ERRFI1	46	Q9UJM3
TVTALSSYDPQMRAI	URB1	1671	O60287
RPNCSSMSSLASIYR	POM121L2	231	Q96KW2
SAYSLPASLNSSIVM	SORBS2	11	O94875
KENPMVQRTSTIYSS	SPAG17	2196	Q6Q759
ETQASLSGPYLTSVM	TCN2	371	P20062
SKLRTSTIMTDYNPN	ALK	1081	Q9UM73
TASGDMQTYQIRTTP	ATF1	171	P18846
MQTYQIRTTPSATSL	ATF1	176	P18846
MTATLRPYLSAVRAT	ARPC4	1	P59998
SQTQSTLTAPLYNTM	CLOCK	651	O15516
IETGQSYTILSNRTM	FAP	81	Q12884
SYQMRLPLVSRSTVS	SPATA4	171	Q8NEY3
SITVPRSMQNSTYGL	TECTA	1226	O75443
SPALTASQAQMYLRA	PHC2	176	Q8IXK0
NLMPLSRGSSVIAYS	TTC13	761	Q8NBP0
SIPAMSSRDLYATIT	SAGE1	471	Q9NXZ1
ISVLSASPVSDVSYM	TNS4	271	Q8IZW8
ANRFLSTAAVSLMTP	RNF123	681	Q5XPI4
NTFSQIYMETSLVPS	RBAK	116	Q9NYW8
MLSRESSSQAPYKSV	FGD6	726	Q6ZV73
LPSSKLMAVNVTYSS	TENM3	1811	Q9P273
YASMVPSSQGNLSIL	VPS13C	2466	Q709C8
LSQSMTPFTYAVSLT	PKHD1L1	2076	Q86WI1
YTASLTRTPYTASLM	nan	476	A8MUU9
NSAMQPDLTVSRTYS	UNC5D	441	Q6UXZ4
RVYQMPSFLQSVASV	PRKDC	406	P78527
LTQLTQSSMYSLPNA	TPGS2	101	Q68CL5
TRVYQTMSNPLSKLS	TRPM1	186	Q7Z4N2
ASNIYSAMLVSPTNS	TMEM245	836	Q9H330
PSGQLTSLSEYASRM	TRAP1	476	Q12931
PTSNSTYLTMNAASR	ZNF462	296	Q96JM2
TYLTMNAASREIPNT	ZNF462	301	Q96JM2
PLRYRSSSSTEQSLM	ZNF687	1111	Q8N1G0
MELLRTITYQPAAST	PLK2	1	Q9NYY3
QVAEMLSASRYPTIS	ZBED1	406	O96006
KRDYTPSTNSLVSMA	TSBP1	76	Q5SRN2
YTSSMRAKYLATSQP	TTYH3	501	Q9C0H2
LSNSSMLPTLSDTYI	TG	746	P01266
SIIYLTADSPNVMTT	TRMT10C	286	Q7L0Y3
MRAVSANYSTGSPAV	nan	1	Q499Y3
ITRSNSMPTTGYSAV	HIVEP1	836	P15822
NRQIMAPVTNSSSYS	WNK3	966	Q9BYP7
SAYDALPSTTIVSMA	AGL	636	P35573
LPEMSTQSASRYFVT	MXRA5	1621	Q9NR99
TMSSSLYASSQLNRP	PPP1R12A	786	O14974
GLQTSSYLMSTRSFP	NEFL	426	P07196
STVSSSYKRSMLAPR	NEFM	46	P07197